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ABSTRACT
The obesity epidemic is a major health and economic burden in the United States with
approximately 35% of the population classified as overweight or obese, and annual medical costs
for obese persons is approximately 150% more relative to lean persons. Obesity can develop
when energy intake exceeds energy expenditure, and the stomach-derived orexigenic hormone
ghrelin has emerged as a key mediator of this balance in humans due to its increased circulating
concentrations in obese persons and involvement in regulating ingestive behaviors and numerous
metabolic processes. We and others have previously shown ghrelin is sufficient to drive both
appetitive (i.e. the searching for and storage of food) and consummatory (i.e. the consumption of
food) ingestive behaviors and metabolic processes such as gut motility, nutrient partitioning,
glycemia, and body temperature. The ghrelin receptor, growth hormone secretagogue receptor

1a (GHSR), is widely expressed in the brain and on gastrointestinal vagal sensory neurons, and
neuronal GHSR knockout affords protection against diet-induced obesity and glycemic
dysregulation. Hence, the absence of ghrelin signaling results in a profoundly beneficial
metabolic profile and elucidating the mechanisms through which ghrelin mediates ingestive
behaviors and metabolic processes may provide novel obesity treatment options. Targeted
central/peripheral ghrelin injections or neuronal-specific GHSR restoration in otherwise GHSRnull mice has provided mounting evidence for discrete neuroanatomical mechanisms regulating
ghrelin’s behavioral and metabolic effects, yet a thorough interrogation of these distributed
signaling pathways in the context of ghrelin-mediated ingestive behaviors or metabolism has yet
to be conducted. Here, we utilize two rodent models (Siberian hamsters and mice) to examine
the mechanisms through which ghrelin regulates ingestive behaviors and overall metabolic
homeostasis. We find that central ghrelin signaling is necessary and sufficient to drive appetitive
and consummatory ingestive behaviors and that hypothalamic agouti-related peptide is critical
for ghrelin-induced appetitive, but not consummatory, behaviors. In addition, we identify a
novel, peripheral sensory neuron ghrelin signaling pathway that is critical for regulating energy
expenditure and metabolic homeostasis. Thus, this dissertation provides a significant step
forward for our understanding of ghrelin signaling and the discrete mechanisms through which it
mediates behaviors and metabolic processes.
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1.1

INTRODUCTION

Global rise of the Obesity Epidemic

Over 1.4 billion people worldwide are classified as overweight or obese with the number
of affected persons nearly doubling in developed countries and tripling in developing countries
since 1980 [1]. As obesity is closely associated with a myriad of secondary health consequences
including diabetes, stroke, and some types of cancers, the resulting annual medical costs for
obese persons is approximately 42% higher than lean persons [2]. The dramatic increase in
obesity rates and resultant economic impact is due, in part, to an increasingly sedentary lifestyle
coupled with the prevalence of inexpensive, calorically dense foods with long shelf lives. To
this end, obesity can develop when energy intake exceeds energy expenditure, and there are
multiple behavioral and metabolic factors that contribute to this imbalance and can compound
the effects of consuming energy rich foods and a sedentary lifestyle. Daily fluctuations in
orexigenic (e.g. the stomach derived hormone ghrelin [3]) or satiety hormones (e.g. leptin [4])
correspond with physiological changes that mediate the searching for and storage of food, energy
conservation, or the liberation of energy stores [5-11]. Hence, a comprehensive interrogation of
the ethological, genetic, and neuroanatomical mechanism through which animals (including
humans) regulate energy homeostasis is critical for stopping the obesity epidemic.

Previous work on the neuroendocrine control of energy homeostasis has largely focused
on uncovering the central (i.e. brain) mechanisms regulating food intake and peripheral
metabolism and, in the process, identified a detailed neuroanatomical framework regulating these
outputs. However, both central and peripheral endocrine signaling is critical for metabolic
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control, and uncovering the distributed systems regulating excessive weight gain through
behavioral and non-behavioral mechanisms will inevitably lead to better treatment options to
reduce the obesity epidemic. Therefore, the overall goal of this dissertation is to investigate how
discrete central and peripheral neuroendocrine signaling regulates behavior and metabolism, with
a focus on the orexigenic hormone ghrelin which has been identified as a key mediator of energy
homeostasis.
1.2

Ethological and Neuroendocrine Control of Body Mass

Obese and lean animals, including humans, have clear differences in the physiological
mechanisms regulating metabolism and ingestive behaviors [12, 13], yet previous studies
examining the neuroendocrine control of energy homeostasis have primarily focused on food
intake and largely ignored the appetitive behaviors that bring animals into contact with food. To
this end, humans invariably search (forage) for food (e.g. at grocery stores and restaurants) prior
to consumption, and numerous studies have suggested overweight and obese persons purchase
more calorically dense foods and store these foods (hoard) for longer periods of time compared
with lean persons (e.g. in cupboards and refrigerators) [14-17]. In an evolutionary context, an
adaptive response to energetic challenges in which animals increase food hoarding, rather than
overeat, upon locating food would prove beneficial for two reasons: first, a surplus of stored food
would allow an animal to expend minimal energy to acquire the next meal and thus expedite the
replenishment of lost calories; second, the long-term storage of food would mitigate the potential
for future negative energy balances. Caloric restriction is the most potent stimulator of food
foraging and food hoarding in humans and laboratory rodents, and it elicits a profoundly
negative valence signal mediated, in part, through neuroendocrine signaling that drives energy
conservation and food seeking behaviors to prevent starvation and replenish energy stores [18,
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19]. These energy stores are maintained through a tightly regulated network involving the brain
and periphery, and peripheral organs such as the stomach and adipose tissue can communicate
with central nuclei through neuronal and/or endocrine signaling mechanisms [11, 20, 21].
Indeed, we and others have previously identified numerous peripheral endocrine signals, whose
circulating concentrations are dependent on caloric state, that are sufficient to modulate ingestive
behaviors, adipose tissue metabolism, and energy expenditure through activation of brain nuclei
[22-26]. This behavioral and metabolic response to caloric deficiency would increase the
survival probability of ancestral humans, but when coupled with the advent of calorically dense
foods with long shelf-lives it directly contributes to the obesity epidemic in contemporary
society.

As the behavioral and metabolic parameters regulating energy homeostasis are often
mediated by the same neuroendocrine mechanisms, it is logical to classify the concomitant
responses to caloric imbalance as either behavioral or metabolic. At the most basic level,
maintaining energy homeostasis necessitates central and peripheral mechanisms that relay
nutrient state to avoid overeating or starvation. For instance, ghrelin promotes caloric intake and
adiposity through a marked increase in food foraging, food hoarding, and food intake (i.e. a
behavioral response) while simultaneously decreasing fatty acid utilization and liberation (i.e. a
metabolic response) [22, 27-31]. In the context of adipose tissue metabolism and energy
expenditure, this ghrelin signal → central/peripheral nuclei → adipose metabolic response can
manifest through altered sympathetic nervous system (SNS) outflow [32-36]. The SNS is the
primary driver of lipolysis, and changes to SNS outflow is sufficient to modulate whole body
energy expenditure [33, 37-43]. Indeed, central ghrelin injections that circumvent peripheral
receptors are sufficient to mediate both ingestive behaviors and sympathetic outflow [35, 44-47],
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yet emerging evidence suggests these responses are mediated by a complex, distributed ghrelin
signaling network. Direct brain activation can occur directly through humoral circulating [4851], and numerous central nuclei critical for metabolic control are circumventricular organs
exposed to circulating ghrelin [51-55]. By contrast, ghrelin responsive enteric sensory neurons
emanating from the vagus nerve and dorsal root ganglia (DRGs) can facilitate rapid crosstalk
with the brain [56-59], and previous work has demonstrated ghrelin activation of hindbrain or
vagal sensory neurons is sufficient to mediate food intake, energy expenditure, and adipose
tissue metabolism [60-62]. These vagal and DRG sensory neurons can synapse with hindbrain
nuclei that project to, and receive projections from, numerous hypothalamic nuclei critical for
both ingestive behaviors and metabolic control [63-66], and presence of multiple pathways
regulating energy homeostasis may provide the basis through which peripheral endocrine signals
drive behaviors and/or metabolic processes. In support of this, ghrelin microinjections into
hypothalamic nuclei is sufficient to drive a rapid, robust increase in ingestive behaviors, whereas
microinjections into the hindbrain can decrease SNS outflow and energy expenditure
independent of food intake effects [47, 67-72]. As previous work has predominantly focused on
a single experimental outcome (i.e. food intake or augmented metabolic processes), an approach
that examines both behavioral and non-behavioral control of whole-body energy homeostasis
represents a novel paradigm to combat the obesity epidemic.
1.2.1 Siberian hamsters as a model to study ingestive behaviors

Animal models used to study obesity have largely consisted of mice and rats, and the
advent of genetic modification in these animals has provided a paradigm shift in how we can
interrogate the neuroendocrine mechanisms regulating metabolism. However, genetic mutations
account for less than 5% of obesity cases in people [73], and mice and rats have limited use for
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obesity related behavioral studies because they do not naturally hoard food. By contrast,
Siberian hamsters (Phodopus sungorus), like humans, are natural and prodigious food hoarders
[74-76]. Siberian hamsters housed in short day photoperiod (8 hours light) accumulate up to
50% body mass (a state that would be considered morbidly obese in humans) and simultaneously
increase the amount of food hoarded [74, 76-78]. Hence, these animals provide an ideal model
to study ingestive behaviors in the context of obesity as they display similar changes in food
intake, food foraging, and food hoarding as obese humans.
Interrogating the mechanisms regulating appetitive and consummatory behaviors
necessitates the use of a unique experimental set up in which food foraging, food hoarding, and
food intake can be delineated. To accomplish this, we have previously developed a novel
foraging/hoarding apparatus consisting of a transparent foraging cage, in which food is earned
through wheel running, and an opaque hoarding cage in which the animal sleeps and stores food
(Fig. 1.1) [79]. In brief, a
running wheel present in the
top, foraging cage is fitted
with a magnet and a magnet
detector connected to a
computer is placed on the
metal cage lid. For every 10wheel revolutions, a food
pellet is dispensed and the
animal can either 1)
immediately consume the

Fig. 1.1 Diagram of foraging and hoarding apparatus.

6

pellet, 2) leave the pellet in the foraging cage, or 3) take the pellet from the foraging cage
through PVC tubing down to the bottom, hoarding cage for storage. Wheel revolutions
(foraging), food intake, and food hoarding is then measured daily for all animals. Using Siberian
hamsters and our unique foraging/hoarding apparatus, we have begun to identify a detailed
neuroendocrine framework driving appetitive and consummatory ingestive behaviors [76-78].
1.3

Ghrelin Regulates Ingestive Behaviors and Metabolism

Ghrelin is a peptide hormone released by X/A-like stomach cells, and has received
considerable attention for its role in obesity development as it is the only known peripheral
orexigenic signal [3, 80, 81]. Pre-pro-ghrelin is modified into its active, acylated form acylghrelin (henceforth referred to as ghrelin) by the protein ghrelin O-acyl-transferase (GOAT) [3,
82]. Unacylated ghrelin, des-acyl-ghrelin, has limited biological functionality in the context of
ingestive behaviors and appears to signal through an alternate mechanism than acylated ghrelin
(for review see [83]). Circulating ghrelin levels rise pre-prandially (i.e. during fasting) and
decrease post-prandially, and the rise and fall of ghrelin concentrations is suggested as a
contributor to normal energy homeostasis and overall metabolic health [84, 85]. Elevated
ghrelin levels underlie pathologies including Prader-Willi Syndrome that are characterized by
obesity, unrestrained feeding and hoarding of food and food-related objects indicating an
important link between obesity and atypical ingestive behaviors [86, 87]. The marked increase
in appetitive and consummatory behaviors following fasting corresponds with elevated plasma
ghrelin concentrations [84, 88], and we have previously demonstrated an exogenous ghrelin
challenge drives food foraging, hoarding, and intake in Siberian hamsters [22]. Fasting or an
exogenous ghrelin challenge acutely increases food intake, but results in a rapid and prolonged
increase in food hoarding behavior (5-7 days) [22]. This long-term behavioral adaptation to
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caloric deficiency is of particular importance as it, in part, underlies the frequent weight regain
following caloric restriction (e.g. during a diet), and understanding the mechanism through
which long-term behavioral responses are regulated is critical for sustained weight loss. To this
end, there are presently several pharmacological treatments aimed at blocking either the ghrelin
peptide directly or GOAT, the enzyme responsible for the conversion into its active, acylated
form [82, 89]. Ghrelin blockade with a single anti-ghrelin Spiegelmer injection blocks acute
fasting-induced ingestive behaviors but has no effect on food foraging and hoarding past 48
hours due to compensatory increases in circulating ghrelin [90]. By contrast, blockade of ghrelin
acylation by GO-CoA-Tat-mediated GOAT inhibition significantly decreases food intake and the
long-term (2-3 day) increase in food hoarding following an overnight fast [91]. This sustained
attenuation of food hoarding is notable in that GOAT inhibition persists for only 6 hours [92],
suggesting an initial blockade of ghrelin signaling is sufficient to inhibit the chronic increases in
appetitive behaviors following energetic challenges.
In addition to driving ingestive behaviors, ghrelin markedly increases adiposity through
its effects on numerous metabolic processes. Central ghrelin administration activates key
enzymes promoting fatty acid storage while simultaneously inhibiting fat oxidation in an SNS
dependent manner, independent of food intake or energy expenditure [93]. Moreover, central
ghrelin infusion inhibits glucose-stimulated insulin secretion and impairs glucose tolerance in
healthy humans, and the ghrelin system has in turn been proposed as a possible target for
diabetes treatment [70, 94]. The dual role of ghrelin in driving appetitive behaviors, which
require energy expenditure, and promoting energy conservation must therefore be balanced. A
possible mechanism underlying this balance is the presence of multiple signaling pathways that
mediate the discrete ingestive and metabolic effects of ghrelin. Although this hypothesis has not
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been directly tested, several independent studies strongly point to discrete systems regulating
ghrelin’s effects on ingestive behaviors and metabolic processes. Ghrelin microinjections into
several hypothalamic nuclei including the hypothalamic arcuate nucleus (Arc) or paraventricular
hypothalamus (PVH) are sufficient to drive food intake and decrease energy expenditure whereas
hindbrain microinjections into the caudal brainstem are sufficient to regulate energy expenditure
and, to a lesser extent, food intake [68, 69]. It should be noted that within the Arc, ghrelin
activates neurons that broadly project to hindbrain nuclei and may therefore mediate energy
expenditure through these pathways and food intake through separate projections [95]. Indeed,
only a subset of Arc, ghrelin sensitive neuronal projections is sufficient to drive food intake, but
the function of the remaining projections remains unclear [95].
1.3.1 The ghrelin receptor

In addition to circulating ghrelin levels, fasting markedly increases expression of its
receptor, growth hormone secretagogue receptor 1a (GHSR) [96, 97]. GHSRs are broadly
expressed in the brain and on gastrointestinal vagal sensory neurons [98, 99], and the orexigenic
effects of ghrelin are entirely mediated through GHSRs as exogenous ghrelin fails to induce food
intake in rodents lacking this receptor [100, 101]. Moreover, pharmacologic activation of
GHSRs, independent of ghrelin manipulation, markedly increase ingestive behaviors indicating
GHSR signaling is sufficient to mediate appetitive and consummatory feeding behaviors [102].
In line with the pharmacological approaches targeting the ghrelin peptide directly, several GHSR
antagonists have been developed including MK-0677, L692,585, and [d-Lys3]-growth hormonereleasing peptide-6 (Dlys), JMV2959, and [d-Arg(1),d-Phe(5),d-Trp(7, 9),Leu(11)]-substance P
(SP-analog) [103]. Of these GHSR antagonists, JMV2959 is highly selective and has proven
effective at reducing ghrelin- and food deprivation-induced food intake in rodents as well as
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food-based reward behaviors [103-106]. Although GHSR antagonism is sufficient to acutely
reduce food intake, the long-term effects of GHSR antagonist administration, the specific
mechanisms through which this antagonism mediates its effects, and it’s potential to inhibit or
attenuate ghrelin- or food deprivation-induced food foraging and food hoarding remains unclear.
1.3.2 Metabolic effects of ghrelin or GHSR knockout
Following the discovery of ghrelin by Kojima et al., several ghrelin-deficient rodent
models have been developed. Whole body ghrelin or ghsr deletion imparts a profoundly
beneficial metabolic phenotype in high-fat-diet fed mice [100, 107]. As ghrelin was initially
identified as an appetite stimulating hormone, it would be logical that ghrelin or ghsr knockout
models would resist obesity development through decreased food intake. However, these
knockout mice have comparable food intake with wild type littermates, yet they have markedly
reduced body mass on high fat diet due to increased energy expenditure and a shift toward higher
lipid utilization [108, 109]. In addition, these mice have improved glucose disposal and insulin
sensitivity compared with high-fat-diet fed wild type controls suggesting the absence of ghrelin
protects against Type 2 Diabetes development [108]. The comparable food intake of ghrelin or
ghsr deficient and wild type mice strongly suggests ghrelin is not an essential meal initiation
hormone and supports the presence of multiple mechanisms through which ghrelin can regulate
caloric intake and metabolic processes. To this end, numerous central and peripheral ghrelin
signaling pathways have been identified (see below), and deconstructing these discrete pathways
has revealed a complex network regulating ghrelin’s effects. Selective Arc ghsr restoration in
otherwise ghsr-null mice restores ghrelin-induced food intake and partially regulates glycemic
dysregulation, yet selective restoration in hindbrain Phox2b neurons is sufficient to restore
glycemic control only [70, 110]. The sufficiency of hindbrain ghsr restoration to mediate
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glycemic control is notable as Phox2b neurons are present in the periphery therefore suggests
peripheral ghrelin signaling is involved in glycemic control whereas Arc signaling drives food
intake [111, 112]. Moreover, the authors did not examine the mechanisms through which Arc
ghrelin signaling regulates glycemia, but emerging evidence suggests these neurons act through
downstream nuclei in the hindbrain. In particular, the nucleus tractus solitarius (NTS) and dorsal
motor vagus (DMV) have been recognized for their role in ghrelin-mediated energy homeostasis
[55, 113]. These studies collectively indicate clear physiological roles for ghrelin in regulating
body mass and adiposity, and it is increasingly evident that ghrelin’s diverse metabolic effects
are mediated through a complex, distributed system that remains to be fully elucidated.
1.4

Ghrelin Signals Through Discrete Central and Peripheral Pathways

The broad central and peripheral GHSR expression evident in laboratory rodents strongly
suggests the diverse effects of ghrelin are mediated through discrete tissues and signaling
pathways. In the context of obesity, neuronal ghrelin signaling is necessary for obesity
development and glycemic dysregulation during high fat diet feeding [107]. Initial GHSR
characterization identified the vagus nerve, which densely innervates the gastrointestinal system,
as the primary ghrelin signaling pathway and critical for ghrelin’s metabolic effects [57, 114,
115]. However, further studies found that a subdiaphragmatic vagotomy has no effect on
ghrelin-induced food intake or gastric motility suggesting that either brain GHSRs or non-vagal
sensory neurons are sufficient to mediate ghrelin’s effects independent of the vagus nerve [116,
117 , 118, 119]. To this end, central GHSR expressing neurons have been identified in diverse
areas including the hippocampus, ventral tegmental area, hypothalamus, and dorsal motor vagus
(DMV), and several studies have identified non-vagal sensory neurons within the gut, likely
emanating from DRGs, as ghrelin responsive [117, 120]. Although these studies have begun to
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elucidate the separate and shared mechanisms through which central and peripheral GHSR
signaling regulates energy homeostasis, it remains unclear whether sensory neurons (i.e. both
vagal and non-vagal) are necessary for ghrelin’s effects, whether central GHSR activation is
necessary for appetitive behaviors in addition to consummatory behaviors, and the
central/peripheral mechanisms through which ghrelin drives acute and chronic changes in
ingestive behaviors and peripheral metabolic processes.
1.4.1 Ghrelin signaling in the brain
1.4.1.1 Hypothalamic arcuate nucleus

Numerous studies have implicated the Arc as a key regulator of metabolism and food
intake [11, 27, 121, 122]. The Arc contains more than 50 unique neuronal populations, many of
which are critical for food intake regulation [123-125], and it has been hypothesized as a key link
between central and peripheral endocrine signaling due to the absence of a normal blood brain
barrier [126]. Within the Arc, GHSRs are most strongly expressed on neurons that co-release the
neurotransmitters agouti-related protein (AgRP) and neuropeptide Y (NPY)- AgRP neurons
[110]. Arc ablation in adult animals blocks the orexigenic action of a peripheral ghrelin
challenge and results in profound hypophagia leading to death [127, 128]. In the context of
appetitive behaviors, neonatal Arc destruction in Siberian hamsters has no effect on baseline
food foraging or food hoarding [129], yet food deprivation in these animals markedly increases
food hoarding upon refeeding suggesting compensatory mechanisms are sufficient to maintain
basal appetitive behaviors independent of the Arc [129]. However, it should be noted that Arc
destruction following NPY-saporin or monosodium glutamate treatment is unable to completely
ablate all Arc neurons [129], and recent work has demonstrated as few as 400 AgRP neurons are
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sufficient to drive food intake in mice [95]. Therefore, even in the absence of compensatory
mechanisms, the intact AgRP/NPY neurons not destroyed by saporin or monosodium glutamate
may be sufficient to regulate appetitive behaviors.

Exogenous ghrelin markedly increases AgRP/NPY expression and AgRP neuron c-Fosimmunoreactivity (-ir), a marker of neuronal activation [122, 130], and central administration of
AgRP and NPY significantly increases both appetitive and consummatory ingestive behaviors in
Siberian hamsters [131-133]. The integral role of Arc AgRP ghrelin signaling is further
supported by the findings that 1) pharmacogenetic or optogenetic AgRP neuron activation drives
a rapid and robust food intake response [134, 135], 2) mice lacking AgRP/NPY do not increase
food intake in response to an exogenous ghrelin challenge [136], and 3) selective reexpression of
GHSRs on AgRP neurons in otherwise ghsr-null mice restores ghrelin’s orexigenic effects [110].
These results collectively indicate the Arc is the primary regulator of ghrelin-induced appetitive
and consummatory ingestive behaviors, and AgRP neurons are necessary for ghrelin’s orexigenic
actions in adult animals. Recent advances in neuron-specific circuit mapping has elucidated
numerous downstream nuclei that control AgRP-induced ingestive behaviors. Discrete
activation of AgRP→anterior bed nucleus of the stria terminalis, AgRP→PVH, or
AgRP→lateral hypothalamus neurons drive food intake comparable to total Arc AgRP activation
indicating the presence of parallel pathways mediating, at the very least, food intake [95, 134].
By contrast, AgRP→parabrachial nucleus, periaqueductal gray, or central amygdala projections
have no effect on food intake, and may therefore regulate energy expenditure rather than food
intake [95]. This hypothesis is supported by the findings that many of these hindbrain nuclei
also express the GHSRs and are involved in sympathetic outflow to adipose tissues [120, 137].
While the role of these parallel pathways in the context of energy expenditure and food foraging
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and food hoarding remains relatively unstudied, AgRP→PVH projections have received
considerable attention for their role in driving appetitive behaviors [28, 138-141]. Indeed, we
have previously demonstrated the PVH is integral in regulating food foraging, food hoarding,
and food intake in Siberian hamsters [28], and the discrete mechanism through which the PVH
regulates these behaviors is actively being investigated.

Although AgRP neuron activation rapidly drives food intake in satiated animals, NPY
and AgRP peptide signaling appears to mediate ingestive behaviors through discrete temporal
mechanisms. Studies in mice have demonstrated that NPY promotes rapid, but transient
increases in food intake while AgRP drives food intake in a delayed, but prolonged, manner
[134, 142]. In Siberian hamsters, intracerebroventricular NPY results in a pronounced (~500%1000%), but transient (<48h), increase in ingestive behaviors whereas AgRP drives long-term
(~7D) food hoarding to a greater extent than food intake. The robust, delayed effects on food
hoarding following a central AgRP challenge closely mimics the timeframe in which the
maximal increase in food hoarding is seen following exogenous ghrelin or food deprivation [22,
28]. It is thus likely that the long-term increases in food hoarding following food deprivation or
a peripheral ghrelin challenge are due to AgRP signaling, and the acute increases in food intake,
food foraging, and food hoarding are regulated by NPY. In addition, recently developed mouse
models allowing for real-time neuronal recording have demonstrated Arc AgRP neurons are
rapidly modulated by sensory detection of food independent of caloric intake [143]. In a
calorically depleted state, in which AgRP neuron activity is markedly increased relative to a
satiated state, sensory detection of food rapidly inhibits AgRP activity (within seconds) prior to
caloric intake [143]. This inhibition is reversed if food is removed prior to consumption
suggesting the modulation of AgRP neurons following food presentation is a mechanism to stop
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foraging and promote feeding. Moreover, as hunger (and, hence, increased AgRP neuron
activity) imparts a profoundly negative valence teaching signal [18], inhibiting AgRP neurons
upon food discovery may be due to a learned correlation between finding food and consuming or
storing the food for future meals.
1.4.1.2 Midbrain nuclei
In addition to forebrain Arc AgRP neurons, GHSRs are strongly expressed in midbrain
[98]. The midbrain ventral tegmental area (VTA) is recognized as a key regulator of the reward
system and is characterized by its dense dopaminergic neuron population [144, 145]. Many of
these dopaminergic neurons express GHSRs, and ghrelin has been proposed as a mediator of
food-related reward and motivation [106, 146, 147]. Indeed, ghrelin microinjections into the
VTA markedly increase sucrose self-administration and food intake [105, 148], and ablating
VTA dopaminergic neurons blocks ghrelin's ability to elicit food-reinforced behavior [149]. In
an evolutionary context, it is logical for ghrelin to increase the motivation to find food (i.e.
foraging behavior) and mediate the subsequent reward signals once the food is found. Caloric
depletion is an inherently negative valence signal that drives an animal to search for food (see
above), and concomitant reward circuitry activation by ghrelin would help ensure an animal
continues to forage for food to prevent starvation. It is notable that the VTA, unlike the Arc, is
not recognized as a circumventricular organ exposed to circulating nutrients or endocrine signals,
and it is therefore unclear how endogenous ghrelin activates these neurons. To this end, ghrelin
mRNA has been localized to periventricular neurons adjacent to the Arc that project to AgRP
neurons [29], but whether the VTA is a downstream target of these neurons was not investigated.
Future studies are clearly needed to elucidate the mechanism through which ghrelin activates
VTA neurons and would provide further insight into ghrelin’s effects on the reward system.
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1.4.1.3 Hindbrain nuclei
GHSR-positive neurons have been identified in hindbrain nuclei including the DMV,
NTS, and area postrema [120], and 4th ventricular ghrelin injection induces food intake and cFos
expression in these areas [67, 68, 150]. Converging evidence suggest these hindbrain GHSRpositive nuclei can function independently of the forebrain. 3rd ventricular ghrelin infusion is
sufficient to drive food intake and induce hindbrain cFos, yet 4th ventricular ghrelin injections
increase food intake but not forebrain cFos [67, 68, 150]. In addition, glutamatergic neuronal
stimulation in the lateral hypothalamus activates NTS GHSR-positive neurons and promotes
gastric motility [151]. Hence, current evidence suggests the presence of discrete forebrain and
hindbrain ghrelin signaling pathways such that hypothalamic GHSR activation can elicit effects
locally and in downstream hindbrain nuclei, but hindbrain GHSR activation may only act locally.
To this end, GHSR restoration in hindbrain Phox2b expressing neurons is sufficient to restore
ghrelin’s glucoregulatory, but not food intake, effects [70], but GHSR restoration in AgRP
neurons is sufficient to partially restore both ghrelin-induced food intake and glycemic regulation
[110]. A notable limitation of these studies is 1) Phox2b is expressed in both hindbrain and
vagal sensory neurons which precludes specificity [111, 112], and 2) hypothalamic GHSRpositive neurons project to hindbrain nuclei and it is therefore unclear where these effects are
being mediated [95].
NTS and DMV neurons act as a critical relay between visceral stimuli and central
integration, and crosstalk between these nuclei is sufficient to regulate neuronal efferent activity
[152, 153]. Gastric afferents synapse in both the DMV and NTS, and GABAergic NTS neurons
tonically inhibit DMV efferents [154-156]. Because GHSRs are distributed on multiple NTS
neuron types including GABAergic and noradrenergic neurons [157, 158], it is likely ghrelin’s
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discrete hindbrain effects (i.e. gastric motility or food intake) are mediated through spatially
unique neurons and downstream targets. Indeed, NTS GHSR-positive neurons are segregated
and would provide a neuroanatomical basis for this functional distribution. Caudal GHSRNTS
neurons respond to gastric mechanostimuli whereas rostral GHSRNTS neurons respond to
energetic challenges including fasting or HFD feeding [157]. However, the mechanism through
which peripheral ghrelin activates or inhibits hindbrain nuclei and which hindbrain GHSR
signaling pathways regulate specific metabolic effects remains unclear and requires additional
studies.

1.4.2 Peripheral ghrelin signaling

The peripheral mechanisms regulating ghrelin’s effects have received considerably less
attention compared with the central mechanisms. Peripheral sensory neurons that innervate the
gastrointestinal system provide a rapid signaling pathway through which viscerosensory
information and gut endocrine signals can be relayed to the brain. The gut is highly innervated
by vagal and non-vagal sensory neurons emanating from DRGs, yet few studies have
interrogated the role of ghrelin signaling in these neurons [59]. Activation of vagal sensory
neurons that detect gastric nutrients or stretching decreases food intake [60, 61] and increases
energy expenditure and brown adipose tissue (BAT) thermogenesis [62]. Ghrelin directly
inhibits these vagal neurons indicating an important link between the gastrointestinal system,
ghrelin signaling, and energy homeostasis control [57]. Enteroendocrine sensory integration can
occur in hindbrain nuclei, such as the NTS and DMV, that regulate metabolic processing of food,
nutrient partitioning, and behavioral outputs [159-163]. Moreover, these hindbrain nuclei project
to, and receive projections from, numerous hypothalamic nuclei critical for ingestive behaviors
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including the Arc and PVH [63-66]. In addition to the vagus, sensory neurons that detect gastric
stimuli and endocrine signals also emanate from DRGs [59], and total sensory neuron ablation
following capsaicin treatment, but not vagotomy alone, impairs cold-induced thermogenic
responses, adipose tissue metabolism, and, at the very least, ghrelin-induced gut motility
indicating sensory nerves are mandatory for metabolic control [119, 164, 165]. Indeed, previous
work has suggested non-vagal sensory neurons regulate exogenous ghrelin-induced gut motility
and decreased energy expenditure [117, 166], yet the mechanism through which these non-vagal
sensory neurons regulate ghrelin-induced ingestive behaviors and/or metabolic homeostasis
remains unclear.

Previous work on peripheral ghrelin signaling has predominantly focused on gut motility
as the peptide was initially characterized by its effects on gastric acid secretion and motility in
humans and rodents [116, 167-169]. Fujino and colleagues demonstrated peripheral ghrelininduced gut motility is not affected by vagotomy alone, but this motility is blocked when ghrelin
is co-injected with a GHSR antagonist in vagotomized animals [170, 171]. In addition, the same
study found central GHSR antagonism had no effect on peripheral ghrelin-induced gut motility
in either normal or vagotomized animals suggesting redundant peripheral mechanisms mediate
ghrelin-induced gut motility independent of the brain [170]. Although peripheral ghrelin has
clear effects on gut motility, few studies have investigated its role in regulating energy
expenditure. In lean humans and rodents, activation of gastric stretch or nutrient receptors
promotes satiety [60, 172, 173], and their activity is directly enhanced by anorectic gut hormones
including CCK and GLP-1and inhibited by ghrelin [61, 174]. in vivo auricular vagus nerve
stimulation or intra-duodenal vagal lipid receptor activation increases sympathetic outflow and
brown adipose tissue (BAT) thermogenesis [62, 175], a key mediator of whole-body energy
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expenditure and adiposity [43, 176]. Currently, no studies have interrogated ghrelin’s role in
activating or inhibiting these neurons, but the presence of GHSRs on these sensory neurons and
the sufficiency of ghrelin to mediate their activity would suggest a role in regulating energy
expenditure. Discrete peripheral ghrelin signaling mechanisms that regulate metabolism
independent of food intake is further evidenced by in vitro studies demonstrating that 1)
exogenous ghrelin markedly increases electrically evoked cholinergic neural responses in rat
stomach strips [117, 177], 2) GHSRs are present in a subset of guinea pig myenteric neurons
[178], and 3) ghrelin evokes calcium efflux through GHSR activation in a subset of myenteric
neurons [179]. These studies collectively suggest peripheral ghrelin signaling on gastrointestinal
vagal and non-vagal sensory neurons is an important mediator of energy homeostasis.
1.5

Dissertation Goals

The goals of this dissertation are to target the separate and shared mechanisms through
which ghrelin regulates metabolic homeostasis. Our overarching question for this dissertation is:
are there discrete mechanisms through which ghrelin regulates acute and chronic appetitive and
consummatory ingestive behaviors, and through what mechanism does ghrelin regulate
metabolic homeostasis independent of food intake. We hypothesize that central ghrelin signaling
primarily through Arc AgRP neurons is the major regulator of ingestive behaviors whereas
peripheral ghrelin signaling regulates energy expenditure and adiposity independent of food
intake.

These dissertation goals were tested across three major experiments. We first examined
whether central or peripheral ghrelin is necessary and sufficient to regulate food foraging, food
hoarding, and food intake using Siberian hamsters in our foraging and hoarding apparatus.
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Hamsters were given either central or peripheral ghrelin in conjunction with a novel ghrelin
receptor antagonist (JMV2915) and food foraging, hoarding, and intake measurements taken
daily. In addition, we characterized the central neuronal activity following an exogenous ghrelin
challenge and JMV2959 administration to uncover the central nuclei involved in the behavioral
phenotype. We next examined the mechanisms through which central ghrelin regulates ingestive
behavior by focusing on Arc AgRP neurons as they are necessary and sufficient for ghrelininduced food intake. We tested whether Arc AgRP, but not NPY, knockdown was sufficient to
block ghrelin- or food deprivation-induced increases in appetitive and/or consummatory
ingestive behaviors using Siberian hamsters in our foraging and hoarding apparatus. Finally, we
examined the role of peripheral ghrelin signaling in regulating metabolic homeostasis using a
GHSR-GFP transgenic mouse and by generating a novel, sensory neuron specific GHSR
knockout mouse. We identified the inherent function of these neurons using energetic challenges
that increase circulating ghrelin (e.g. food deprivation) and characterized the necessity of ghrelin
signaling on these neurons for the development of diet-induced obesity.
Collectively, this dissertation serves as a critical step in our understanding of ghrelin and
the mechanisms through which it regulates metabolic homeostasis. In conjunction with previous
research, this work provides complementary evidence to ghrelin’s role in driving food intake
while simultaneously uncovering the mechanisms through which ghrelin regulates food foraging
and food hoarding independent of food intake. Moreover, this work identifies a novel
mechanism through which peripheral ghrelin signaling regulates metabolic homeostasis through
peripheral sensory neuron signaling.
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2

CENTRAL GHRELIN INCREASES FOOD FORAGING/HOARDING THAT IS
BLOCKED BY GHSR ANTAGONISM AND ATTENUATES HYPOTHALAMIC
PARAVENTRICULAR NUCLEUS NEURONAL ACTIVATION

2.1

Abstract
The stomach-derived “hunger hormone” ghrelin increases in circulation in direct

response to time since the last meal, increasing preprandially and falling immediately following
food consumption. We found previously that peripheral injection of ghrelin potently stimulates
food foraging (FF), food hoarding (FH) and food intake (FI) in Siberian hamsters. It remains,
however, largely unknown if central ghrelin stimulation is necessary/sufficient to increase these
behaviors regardless of peripheral stimulation of the ghrelin receptor [growth hormone
secretagogue receptor (GHSR)]. We injected three doses (0.01 µg, 0.1 µg, and 1.0 µg) of ghrelin
into the third ventricle (3V) of Siberian hamsters and measured changes in FF, FH, and FI. To
test the effects of 3V ghrelin receptor blockade, we used the potent GHSR antagonist JMV2959
to block these behaviors in response to food deprivation or a peripheral ghrelin challenge.
Finally, we examined neuronal activation in the arcuate nucleus (Arc) and paraventricular
hypothalamic nucleus (PVH) in response to peripheral ghrelin administration and 3V GHSR
antagonism. Third ventricular ghrelin injection significantly increased FI through 24 h and FH
through Day 4. Pretreatment with 3V JMV2959 successfully blocked peripheral ghrelin-induced
increases in FF, FH and FI at all time points and food deprivation-induced increases in FF, FH
and FI up to 4h. c-Fos-immunoreactivity was significantly reduced in the PVH, but not the Arc
following pretreatment with i.p. JMV2959 and ghrelin. Collectively, these data suggest central
GHSR activation is both necessary and sufficient to increase appetitive and consummatory
behaviors in Siberian hamsters.
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2.2

Introduction
Obesity is a primary health concern affecting both developed and developing countries

worldwide with an incidence rate of 34.9% in the United States as of 2008 [1]. Comorbidities
associated with obesity include type 2 diabetes, stroke, heart disease, and some cancers [2-7]. As
a result of the increasing rate of obesity and its comorbidities, the health costs associated with
treatment has reached $147 billion [8], making obesity a major health and economic burden.
Many factors, including genetics, contribute to excess weight gain but the primary cause is a
surplus of energy intake compared with energy expenditure. This is compounded by the problem
of easy access to calorically dense, cheap food as well as the ability to store more of these items
for longer periods of time. Thus, understanding the underlying behaviors and neuroanatomical
pathways involved in weight gain is critical to find novel treatments.
Appetitive behaviors include driving to/ shopping for food (foraging) and the storing
(hoarding) of food in cupboards, refrigerators, freezers, and pantries, whereas consummatory
behavior involves the consumption of food [9]. The research to date in the field has largely
focused on consummatory behavior (food intake) in mice and rats, and in the process uncovered
detailed central and peripheral pathways controlling this behavior . Although considerable
attention has been paid to consummatory appetitive behavior, little attention has been paid to
appetitive behaviors such as the hoarding of food and foraging [for review see Ref. 10]. Food
restriction and deprivation in laboratory rats and mice trigger subsequent increases in FI upon reexposure to food [for review see Rev.11]; by contrast, humans and hamsters, contrary to popular
belief and personal anecdotes, instead ‘overhoard,’ storing considerably more food than normal,
but do not overeat [12-15]. Furthermore, when faced with extended food deprivation (~24-48 h)
humans and Siberian hamsters do not exhibit prolonged overeating. Rather than increasing FI
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for extended periods, humans and Siberian hamsters increase FH [12, 14, 16-21]. In both
humans and rodents, periods of negative energy balance directly correlate with increases in
circulating concentration of the endocrine hormone ghrelin [22-24]. Furthermore, peripheral
administration of ghrelin mimics the substantial increases in FF, FH and FI after a 56 h food
deprivation in Siberian hamsters [25, 26] indicating its importance in driving both appetitive and
consummatory behaviors.
Ghrelin acts on its receptor (GHSR) in diverse central and peripheral areas including the
arcuate nucleus (Arc) [for review see Ref. 27], ventral tegmental area [for review see Ref. 28],
suprachiasmatic nucleus [29, 30], paraventricular hypothalamic nucleus (PVH) [31], and vagus
nerve [32]. Within the Arc, ghrelin activates agouti related protein (AgRP) / neuropeptide Y
neurons to increase food intake [27, 33], and the co-administration of these peptides into the 3V
increases FF, FH and FI in Siberian hamsters [34]. Ghrelin-sensitive neurons in the Arc project
to diverse brain areas including the PVH [35, 36] and parabrachial nucleus [37, 38] to stimulate
FI, and peripheral administration of ghrelin triggers c-Fos expression (a marker of neuronal
activation [39, 40]) in these areas [30, 31]. Together these data demonstrate a varied and
multifaceted role of ghrelin in driving appetitive and consummatory behaviors.
The development of direct and indirect ghrelin antagonists have shed light on the
physiological role of ghrelin in rodents. Peripheral administration of an anti-ghrelin Spieglemer
compound [41], as well as inhibition of ghrelin octanoylation, and thus its conversion into its
active form [42], blocks exogenous ghrelin-induced neural activation both peripherally and
centrally (given its route of administration peripherally) and short-term (<48 h) increases in FF,
FI, and FH; however; long term (>48 h) appetitive and consummatory behaviors remain
unchanged. In addition to ghrelin-peptide antagonists, the development of the specific GHSR
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antagonist JMV2959 [43, 44] allows for site-specific studies of ghrelin activity throughout the
brain [45-47]. These studies have partially elucidated the role of ghrelin in Siberian hamsters
and other rodent models, but it remains unclear if central GHSR activation is necessary and
sufficient to drive appetitive ingestive behaviors independent of peripheral GHSR blockade.
Here, we tested the sufficiency of 3V central ghrelin to increase FF, FI, and FH in
Siberian hamsters. After confirming the sufficiency of 3V ghrelin to drive these behaviors, we
then tested the effects of 3V GHSR blockade by administering the GHSR antagonist JMV2959
followed by: 1) a 48 h food deprivation challenge and 2) a peripheral ghrelin challenge. Finally,
we examined neuronal activation as seen by c-Fos immunoreactivity (-ir; [40]) in the Arc and
PVH following peripheral ghrelin administration and 3V GHSR antagonism to further clarify
neuronal activity from two structures implicated in driving appetitive behaviors in Siberian
hamsters.
2.3

Materials and Methods

2.3.1 Animals
Adult male Siberian hamsters (Phodopus sungorus; n = 39) were obtained from our
breeding colony. Hamsters were housed in same same-sex groups in polypropylene cages (48 X
27 X 15cm), given ad libitum access to food (5001, Purina, St. Louis, MO) and water, and raised
in a long-day photoperiod (16:8-h light-dark cycle; light offset 1800) from birth until used in the
following experiment. Room temperature was maintained at 21.0 ± 2.0˚C. At ~2.5-3.0 mo,
animals were transferred and singly housed in polypropylene cages (27.8 X 17.5 X 13.0 cm) with
Alpha-Dri (Specialty Papers, Kalamazoo, MI) bedding and one cotton Nestlet (Ancare, Belmore,
NY). Animals were given ad libitum access to the experimental, pelleted test diet (DPPs,
Purified 75 mg pellets; Bio-Serve, Frenchtown, NJ) and water and housed at 21.0 ± 2.0 ˚C with
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50% humidity ± 10 in 16L:8D (light offset 1300) for two weeks to acclimate to the new light
offset. All procedures were approved by the Georgia State University Institutional Animal Care
and Use Committee and were in accordance with Public Health Service and United States
Department of Agriculture guidelines.
2.3.2 Foraging and hoarding apparatus
Hamsters were acclimated for 1 wk before and after cannula implantation in specially
designed foraging/hoarding set up as previously described [48]. In brief, two cages were
connected using convoluted polyvinylchloride tubing (38.1 mm inner diameter and ~1.5 m long)
with 3 bends containing wire mesh to allow for vertical and horizontal climbing between each
cage. The top, foraging cage was 456 X 234 X 200 mm (length X width X height) and equipped
with a pellet dispenser, running wheel (524 mm circumference), and water bottle. The bottom,
hoarding cage was 290 X 180 X 130 mm (length X width X height) and contained Alpha-Dri
bedding and 1 cotton Nestlet. In order to mimic the darkness of a burrow, the hoarding cage was
opaque and covered with an aluminum pan throughout the duration of the experiment. Wheel
revolutions were measured using a magnetic detection system connected to a computer with
monitoring software (Med Associates, Georgia,VT). Food was available ad libitum for 2 d
following introduction to the foraging and hoarding apparatus. Subsequent to this initial training
period, access to food was removed and all food had to be earned (1 pellet/10 wheel revolutions)
for 5 d, during which time wheel revolutions, FI, pellets earned (FF), food hoarding (FH), and
body mass were measured daily. Following 1 wk acclimation period, animals were placed back
into cages with ad libitum access to food and further used for cannulation surgery.
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2.3.3 Measurement of FF, FH, and FI
FF was defined as the number of pellets earned following completion of the
required 10 wheel revolutions. FH was defined as the number of pellets collected in the bottom,
burrowing cage as well as pellets removed from cheek pouches. FI was defined as the total
number of pellets earned, minus the number of pellets left in the top cage and pellets hoarded.
An electronic balance set to parts measurement was used to count pellets (75 mg = 1 pellet). All
whole and fractions of food pellets were recovered from each cage and hamster food pouches
daily (0900) then quantified as whole pellets using a precision balance set to ‘parts’ whereby one
75 mg food pellet = 1 and fractions of pellets computed by the balance. FF, FH, and FI was
measured daily at 0900 for the duration of the experiment.
2.3.4 Cannula implantation, injections, and verification
Cannulas were stereotaxically implanted into 3V under isoflurane (Aerrane; Baxter
Healthcare, Deerfield, IL) with anesthesia as previously described [49]. In brief, each animal
was anesthetized and head shaved to expose the skull. A guide cannula (26-gauge stainless steel;
Plastics One, Roanoke, VA) was lowered stereotaxically (coordinates: anterior-posterior from
bregma 0 mm, medial-lateral from midsaggital sinus 0 mm, and dorsal-ventral from the top of
the skull -5.5 mm) targeted for the 3V. Cannula were secured to the skull using cyanoacrylate
ester gel, 3/16 mm jeweler’s screws, and dental acrylic. A removable dummy cannula was used
to seal the opening of the guide cannula throughout the experiment. Animals received ketofen (5
mg/kg; s.c; Fort Dodge Animal Health, Fort Dodge, IA) to minimize postoperative discomfort
and an apple slice to facilitate food and water intake for the first 2-3 days postsurgery. Animals
were kept in shoebox-type caging for 2 wk post-surgery for recovery.
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One wk before each test d, each animal was lightly handled for 1 min and the dummy
cannula removed and replaced to acclimate the animal to the injection protocol. On test days, an
injection cannulae (33-gauge stainless steel; Plastics One) extending 0.5 mm beyond the guide
cannula was connected to a microsyringe via PE-20 tubing and inserted into the guide cannula.
All hamsters were injected with 400 nl of ghrelin, JMV2959 or saline vehicle over the course of
30 s and the injector was left in place for 30 s to minimize reflux up the sides of the cannula
before removal as previously described [49].
Following the last behavioral test in Experiment 3, an injection of 400 nl of bromophenol
blue dye was given to each animal to confirm placement of the cannula in the 3V. Animals were
then given an overdose of pentobarbital sodium (100 mg/kg), transcardially perfused with 100 ml
heparinized saline followed by 125 ml of 4% paraformaldehyde in phosphate buffered saline
(PBS; pH = 7.4). Brains were then removed and post fixed in 4% paraformaldehyde for 2 d
followed by a 30% sucrose solution until sectioning. Brains were sectioned on a freezing
microtome at 80 µm and cannulae placement was verified using light microscopy. Cannulae
were considered a hit if blue dye was visible in any part of the ventricle and only these animals
were included in the analysis.
2.3.5 Experiment 1: Does 3V injection of ghrelin increase FF, FI, and FH in Siberian
hamsters?
Following the initial acclimation period, all hamsters were assigned to 4 groups
counterbalanced for body mass, FI, FF, and FH levels. On test days, animals were provided with
a clean burrowing cage and blocked from accessing the top cage to prevent feeding 2 h before
injections. Animals were injected at light-offset with one of four 3V injections: 1) 0.01 µg
ghrelin, 2) 0.1 µg ghrelin, 3) 1.0 µg ghrelin, or 4) vehicle and access to food was returned.
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Following these injections, FI, FF (wheel revolutions), and FH was recorded at 2 h, 4 h, 24 h
post injection and then daily for 8 d. After a 1 wk washout period, a length of time previously
determined to yield a return to baseline, the same protocol was repeated until each animal had
received all 4 treatments (n = 30).
2.3.5.1 Measurement of circulating plasma ghrelin concentrations
To ensure 3V administered ghrelin does not cross the blood brain barrier, a separate
cohort of 36 adult male hamsters were obtained from our breeding colony and singly housed in
polypropylene cages with Alpha-Dri bedding and one cotton Nestlet. Cannula were implanted as
described above and animals were allowed to recover for two weeks with ad libitum food. Daily
food intake and body mass were recorded. Following recovery, animals were counterbalanced
for daily food intake and body mass and, finally, assigned into four groups: 1) 0.01 µg ghrelin, 2)
0.1 µg ghrelin, 3) 1.0 µg ghrelin, or 4) vehicle. Third ventricular injections were given at lightoffset and retro-orbital blood was taken from anesthetized animals according to our previously
published method [42] at 2 h, 4 h, and 24 h post-injection. Circulating acylated ghrelin
concentrations were measured using ELISA (Mouse/Rat Acylated Ghrelin ELISA; Caymen
Chemical) according to manufacturer’s instructions and previously published methods [50]. In
brief, 500 µl of blood was collected using heparinized Natelson tubes, transferred to pre-chilled
BD microtainers containing EDTA (Franklin Lakes, NJ), and inverted ten times. Subsequently,
300 µl of blood was immediately transferred from EDTA tubes to pre-chilled microcentrifuge
tubes containing 300 µl of the transfer buffer (1.2 % 10 N NaOH, 2 mM phydroxymercuribenzoic acid, 500 mM NaCl, and 25 mM EDTA in deionized water), mixed
thoroughly by gentle inversion, and spun at 5,000 rpm at 4˚C for 10 min. Next, 300 µl of plasma
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was transferred to prechilled microcentrifuge tubes, acidified with 1 N HCl (1 µl HCl/10 µl
plasma), spun at 5,000 rpm at 4˚C for 5 min andstored at -20˚C until assayed.
2.3.6 Experiment 2: Does 3V injections of a GHSR antagonist JMV2959 prevent ghrelininduced increases in FF, FI, and FH in Siberian hamsters
Following a 10 d washout period after the final test day of Experiment 1, animals were
assigned to 4 new treatment groups counterbalanced for body mass, FI, FF, and FH levels. In
our pilot studies and based on Jerlhag et al. [51] and Skibicka et al. [51, 52], we determined that
10 µg of the GHSR antagonist JMV2959 was effective in blocking the effects of exogenous
ghrelin while not adversely affecting locomotor activity (M. A. Thomas and T. J. Bartness,
unpublished observations); we thus chose this dose to use throughout the experiment. Treatment
groups consisted of: 1) intraperitoneal (i.p.) Saline + 3V saline, 2) i.p. saline + 3V JMV2959 (10
µg) 3) i.p. ghrelin (30 µg/kg body mass) + 3V JMV2959 (10 µg), and 4) i.p. ghrelin (30 µg/kg
body weight) + 3V saline. On test days, animals were provided with a clean burrowing cage and
prevented from accessing the top cage in the same manner as Experiment 1. All injections were
given concurrently at light-offset and access to food returned. Following these injections, FI, FF,
and FH was recorded at 2 h, 4 h, 24 h, and then daily for 8 d. Following a 1 wk washout period,
the same injection protocol was repeated until each animal had received all treatments (n=20).
2.3.7 Experiment 3: Does 3V injections of a GHSR antagonist block food deprivationinduced increases in FF, FI, and FH?
Following a 10 d washout period after the final test day of Experiment 2, animals were
divided into 2 groups counterbalanced for body mass, FI, FF, and FH levels. Treatment groups
consisted of 1) 3V saline and 2) 3V JMV3959 (10 µg). Animals received injections of either
saline or JMV2959 at the onset of food deprivation (time (T) = 0), T + 24 h, and T + 48 h.
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Following the final injection, access to food was returned and FF, FI, and FH were recorded at 2
h, 4 h, 24 h, and then daily until animals returned to behavioral baseline. After returning to
baseline, animals were transferred to shoebox cages and brain tissue was processed as above to
verify cannulae location (n=20).
2.3.8 Experiment 4: Does 3V injection of a GHSR antagonist prevent ghrelin-induced
increases in c-Fos expression?
Twenty Siberian hamsters were selected from the breeding colony and housed
individually in shoebox cages before and after 3V cannula implantation. A separate, agematched cohort of animals was used for Experiment 4 due to the within-subject design of
Experiments 1, 2, and 3 not allowing for unconfounded test of neural activation. Animals were
divided into 4 treatment groups: 1) i.p. saline + 3V saline, 2) i.p. saline + 3V JMV2959 (10 µg),
3) i.p. ghrelin (30 µg/ kg body mass) + 3V saline, and 4) i.p. ghrelin (30 µg/ kg body mass) + 3V
JMV2959 (10 µg). Animals were injected at light offset and perfused 2 h later. This time point
was chosen because preliminary data showed the largest increases in FF, FI and FH occurring
between 2-4 h [25, 41]. Brains were sectioned at 40 µm on a freezing microtome. For
immunohistochemistry, free-floating brain sections were rinsed in 0.1 M PBS (2 x 15 min)
followed by 30 min incubation in a blocking and permiablization solution consisting of 10.0 %
normal goat serum (NGS) and 0.3 % Triton X-100 in 0.1 M PBS. Sections were incubated
overnight with rabbit anti-c-Fos antiserum (1:800; sc-52, Santa Cruz Biotechnology, Santa Cruz,
CA) in 0.1 M PBS with 0.5 % NGS. For immunohistological controls, the primary antibody was
either omitted or preadsorbed with the immunizing peptide overnight at 4 °C resulting in
abolished immunostaining. Subsequently, sections were washed in 0.1 M PBS (2 x 15 min) and
incubated with biotinylated goat anti-rabbit antibody (1:200; Vector Laboratories, Burlingame,
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CA, USA) for 2 h. Bound secondary antibody was then amplified with the Vector Elite ABC kit
(1:800; Vector Laboratories, Burlingame, CA, USA) and antibody complexes were visualized by
0.05 % diaminobenzidine reaction. After mounting, sections were dehydrated and cleared
through a series of ethanol, isopropanol and xylene solutions. Cleared slides were immediately
mounted with Permount (Thermo Fisher Scientific, Waltham, MA, USA) and cover slipped.
2.3.9 Quantitative and statistical analysis
Images were viewed and captured using 100x and 200x magnification with an Olympus
DP73 imaging photomicroscope (Olympus, Tokyo, Japan). The PVH- and Arc-c-Fos-ir images
were evaluated with the aid of CellSens (Olympus) and the Adobe Photoshop CS5 (Adobe
Systems, San Jose, CA) software. The Arc and PVH were chosen for quantification because
previous studies showed increased neuronal activity in these areas in response to ghrelin [41, 53].
The c-Fos-ir neurons were considered positively labeled based on the nuclei size and shape.
Exhaustive counts of c-Fos positive neurons at the same anatomical level in all animals were
then averaged across all animals within each experimental group. A mouse brain atlas [Paxinos
and Franklin, 2007] was used to identify brain areas because no Siberian hamster brain atlas is
available and because of the similarity in size and shape of most of the brain structures between
Siberian hamsters and mice that are much more similar than the commercially available Syrian
hamster stereotaxic atlas. For the preparation of the photomicrographs, we used Adobe
Photoshop CS5 (Adobe Systems) only to adjust the brightness and contrast, and to remove
artifactual obstacles (i.e., obscuring bubbles) to make the composite plates.
In Experiment 1 and 2, raw behavioral data for each individual animal were transformed
into percent change from saline control before statistical analysis according to the formula: [((Xvehicle)/vehicle) x 100], where X is equal to the measured value in response to experimental
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treatment and vehicle is equal to the value measured for the individual following control
injection (Experiment 1 = 3V saline; Experiment 2 = IP saline + 3V saline). Thus, each animal
serves as its own control and data are reported as a percent change from baseline measurements.
No statistical comparisons were made across the time intervals due to the unequal duration of the
intervals. Behavioral data were analyzed using one-way repeated measures ANOVA across all
treatments within each time point followed by the post-hoc Bonferroni’s test using NCSS
(version 2009, Kaysville, UT). For all measures of foraging, intake, and hoarding in Experiment
1 and Experiment 2, data were reported as the mean percent difference from vehicle control
(100%) ± SEM. Circulating acyl-ghrelin concentrations in experiment 1 were analyzed using
one-way ANOVA at each time point. For Experiment 3, data were not transformed into percent
change because animals were only food deprived once and, therefore, cannot serve as their own
control because Siberian hamsters do not overeat after food deprivation and therefore take weeks
to return to their initial body mass readily. Raw data for FF, FI, and FH were analyzed using
Mann-Whitney U test. For Experiment 4, c-Fos-ir for all groups was analyzed using one-way
ANOVA. Exact probabilities and test values were omitted for simplicity and clarity of
presentation. Differences were considered statistically significant if P < 0.05.
2.4

Results

2.4.1 Experiment 1: Does 3V injection of ghrelin increase FF, FI, and FH?
2.4.1.1 FF
No significant increase in FF was seen across all three doses of 3V ghrelin at all time
points examined compared with saline controls (Fig. 2.1A). A trend of increased FF was
observed at the 2-4 h post injection for both 0.1 µg and 1.0 µg ghrelin doses, but only reached a
maximum increase of ~160 % compared with saline (P = 0.10; Fig. 2.1A).
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2.4.1.2 FI
FI was significantly increased by ~200% of control at 2-4 h post injection for the 1.0 µg
ghrelin dose (P < 0.05 vs. 3V Saline; Fig. 2.1B). No significant increase was seen for 3V
injection of either the 0.01 µg or 0.1 µg ghrelin doses at any time point examined (Fig. 2.1B).
2.4.1.3 FH
3V ghrelin significantly increased FH at 0-2 h through Day 4 for the 1.0 µg dose (P <
0.05 vs. 3V Saline; Fig. 2.1C). FH reached a maximum of ~600% following 1 µg ghrelin
compared with control values at 48 h post injection and gradually declined to baseline at Day 5.
0.1 µg ghrelin significantly increased FH at 2-4 h and Day 3, reaching a maximum increase of
~400% (P < 0.05 vs. 3V Saline; Fig. 2.1C). No increase was observed at any time point for the
0.01 µg ghrelin dose (Fig. 2.1C) compared with the saline control.
2.4.1.4 Circulating acyl-ghrelin concentrations
To ensure 3V administered ghrelin was not crossing the blood brain barrier, we repeated
experiment 1 and measured peripheral circulating acyl-ghrelin concentrations at 2 h, 4 h, and 24
h post-injection. No dose of 3V administered ghrelin significantly affected peripheral circulating
acyl-ghrelin concentrations at any time point examined (Fig. 2.2).
2.4.2 Experiment 2: Does 3V injection of a GHSR antagonist JMV2959 prevent peripheral
ghrelin-induced increases in FF, FI, and FH in Siberian hamsters?
2.4.2.1 FF
FF was significantly increased at the 4-24 h time point for the IP ghrelin + 3V saline
group (P < 0.05 vs. IP Saline + 3V Saline; Fig. 2.3A) by ~350% compared with the control
group. Foraging was attenuated at the 4-24 h time point in animals receiving IP ghrelin + 3V
JMV2959 treatment, reaching a maximum of ~200% compared with saline (P = 0.28; Fig. 2.3A).
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No change from the control treatment was seen across all time points in animals receiving IP
saline + 3V JMV2959 (Fig. 2.3A). Foraging returned to baseline at 48 h for all groups (Fig.
2.3A).
2.4.2.2 FI
FI was significantly increased by ~200% of control at the 0-2 h time point for animals
receiving IP ghrelin + 3V saline (P < 0.05 vs. IP Saline + 3V Saline; Fig. 2.3B). FI was
attenuated at 0-2 h and 2-4 h following IP ghrelin + 3V JMV2959 treatment and reached a
maximum of ~160% at 4-24 h (P < 0.05 vs. IP Saline + 3V Saline). No change in pellets eaten
was observed following IP saline + 3V JMV2959 treatment (Fig. 2.3B).
2.4.2.3 FH
Pellets hoarded were significantly increased at all time points, except for 48 hs, examined
through Day 5 in animals receiving IP ghrelin + 3V saline (P < 0.05 vs. IP Saline + 3V Saline;
Fig. 2.3C), and reaching a maximum of ~400% at Day 5. FH was attenuated in animals
receiving IP ghrelin + 3V JMV2959 treatment at all time points and reaching a maximum of
~200% at Day 5; however, without statistical significance (P = 0.16; Fig. 2.3C). No change in
pellets hoarded was observed for the IP saline + 3V JMV2959 treatment group at all time points.
2.4.3 Experiment 3: Does 3V injection of a GHSR antagonist block food deprivation-induced
increases in FF, FI, and FH in Siberian hamsters?
2.4.3.1 FF
FF was significantly decreased in animals receiving 3V JMV2959 0-2 h and 2-4 h time
points post injection compared with 3V saline control (P < 0.05; Fig. 2.4A). No difference was
observed between the two groups 4-24 h or 48 h post injection (Fig. 2.4A).
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2.4.3.2 FI
Pellets eaten was significantly decreased in animals receiving 3V JMV2959 at 0-2 h post
injection compared with 3V saline control (P < 0.05; Fig. 2.4B). No difference in pellets eaten
was observed 2-4 h, 4-24 h, and 48 h post injection (Fig. 2.4B).
2.4.3.3 FH
FH was significantly decreased in animals receiving 3V JMV2959 0-2 h and 2-4 h post
injection compared with 3V saline control (P < 0.05; Fig. 2.4C). No difference in pellets
hoarded was observed at the 4-24 h through Day 7 for both groups (Fig. 2.4C). Animals
receiving 3V JMV2959 displayed a trend of increased food hoarding following the 48 h time
point, although never reaching statistical significance (Fig. 2.4C).
2.4.4 Experiment 4: Does 3V injection of a GHSR antagonist prevent ghrelin-induced
increases in c-Fos expression?
IP ghrelin significantly increased c-Fos-ir in the Arc compared with IP saline controls (P
< 0.05; Fig. 2.5A, c); however, 3V JMV2959 failed to block ghrelin-induced Arc neuronal
activation (Fig. 2.5A, d). IP ghrelin (30 µg/kg body weight) + 3V saline significantly increased
c-Fos-ir in the PVH (P < 0.05; Fig. 2.5B, g) 2 h postinjection compared with IP saline and
JMV2959 blocked this effect (P < 0.05; Fig. 2.5B, h).
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Fig. 2.1 3V ghrelin drives FF, FI, and FH.
Mean ± SE % difference in FF (A), FI (B), and FH (C) in response to 3V injection of
0.01 µg ghrelin (white bars), 0.1 µg ghrelin (grey bars), or 1.0 µg ghrelin (black bars).
*p<0.05 compared with saline controls; n = 30 for each group.
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Fig. 2.2 3V ghrelin has no effect on plasma ghrelin concentrations.
Mean ± SE of plasma acyl-ghrelin concentrations in animals receiving 3V injection of
saline (white bars), 0.01 µg ghrelin (white, crossed bars), 0.1 µg ghrelin (grey bars), or
1.0 µg ghrelin (black bars). n= 9 for each group.
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Fig. 2.3 Central GHSR antagonism blocks peripheral ghrelin-induced FF, FI, and FH.
Mean ± SE % difference in FF (A), FI (B), and FH (C) in response to i.p. saline + 10 µg
3V JMV2959 (white bars), 30 µg/kg i.p. ghrelin + 10 µg 3V JMV2959 (grey bars), or 30
µg/kg i.p. ghrelin + 3V saline (black bars). *p<0.05 compared with i.p. saline + 3V
saline controls; n = 21 for each group.
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Fig. 2.4 Central GHSR antagonism blocks food deprivation-induced FF, FI, and FH.
Mean ± SE number of wheel revolutions (A), pellets eaten (B), and pellets hoarded (C)
following 48 h food deprivation and 3V injection of saline (white bars) or JMV2959
(black bars). *p<0.05 compared with saline control; n = 10 for each group.
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Fig. 2.5 Central GHSR antagonism blocks peripheral ghrelin-induced c-Fos in the PVH.
Mean ± SE number of c-Fos-ir cells and representative photographs in the Arc (A, a-d)
and the PVH (B, e-h) in response to i.p. saline + 3V saline (a, e), i.p. saline + 10 µg 3V
JMV2959 (b, f), 30 µg/kg i.p. ghrelin + 3V saline (c,g), or 30 µg/kg i.p. ghrelin + 10 µg
3V JMV2959 (d,h). *p<0.05 compared with i.p. saline + 3V saline controls; Scale bar=
100 µm. n = 5 for each group.
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2.5

Discussion
The current study was designed to test the sufficiency and necessity of central and

peripheral GHSR activation to increase appetitive and consummatory behaviors in Siberian
hamsters. Similar to previous reports in laboratory mice and rats [26, 54-56], 3V administration
of ghrelin was sufficient to increase FI in ad libitum fed Siberian hamsters. We showed here for
the first time however that 3V ghrelin is sufficient to increase appetitive and consummatory
behaviors independent of peripheral GSHR stimulation/blockade. We next tested the hypothesis
that central GHSR activation mediates the appetitive and consummatory response to peripheral
ghrelin. The GHSR antagonist JMV2959 successfully blocked exogenous ghrelin-induced
increases in FF, FI and attenuated FH from the first time point measured post injection (2 h)
through the end of the study (8 d). To further elucidate the neuronal mechanism underlying this
effect, we measured c-Fos-ir in the Arc and PVH following administration of 3V JMV2959 and
i.p. ghrelin. Pretreatment with JMV2959 significantly decreased c-Fos positive cells in the PVH
but not in the Arc following a peripheral ghrelin challenge, suggesting peripheral ghrelininduced increases in FF, FI and FH are mediated by neuronal activity in the PVH rather than the
Arc.
In line with previous experiments testing the effects of peripheral ghrelin, 3V ghrelin
potently stimulated both appetitive and consummatory behaviors in Siberian hamsters. By
contrast to i.p. injections [25, 41], 3V administration circumvents possible peripherally mediated
mechanisms driving appetitive and consummatory behavior. For instance, activation of the
stomach-vagal-hindbrain-midbrain axis [32, 57, 58] increases FI whereas 3V administration
prevents peripheral GHSR involvement. 3V ghrelin potently stimulated FF, FI, and FH for both
0.1 µg and 1.0 µg (Fig. 2.1A-C). Furthermore, 3V ghrelin administration closely mimicked the
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drastic increases in FH observed following i.p. injection reaching an apex of ~600% (Fig. 2.1C).
We thus hypothesize that centrally mediated ghrelin activity is sufficient to induce appetitive and
consummatory behaviors independent of peripheral GHSR stimulation/blockade. This is further
supported by our finding that 3V ghrelin does not significantly affect peripheral circulating
ghrelin concentrations and indicates 3V ghrelin does not cross the blood brain barrier. The
marked increase in ghrelin plasma concentration following an exogenous ghrelin challenge or
prolonged food deprivation activates peripheral and central GHSRs and markedly increases FF,
FI, and FH [25]; however, by circumventing peripheral GHSR involvement we have for the first
time directly examined the discrete role of central GHSR activation in driving appetitive and
consummatory behaviors in Siberian hamsters. The central and peripheral distribution of
GHSRs suggests the effects of ghrelin are mediated by a number of distinct areas [59].
Furthermore, our findings here that 3V ghrelin markedly increases FF, FI, and FH independent
of peripheral GHSR activation further supports the presence of multiple, redundant systems
mediating appetitive and consummatory behaviors [60]. Overall, we demonstrated that 3V
ghrelin is sufficient to increase both appetitive and consummatory behaviors independent of
peripheral GHSR1a activation.
Our previous tests on the necessity of ghrelin focused on peripheral mechanisms to block
ghrelin directly [41] or prevent its conversion into its physiological active form [42] without
directly blocking its receptor. We therefore tested the necessity of central GHSR activation to
increase FF, FI, and FH in response to a peripheral ghrelin challenge using the potent GHSR
antagonist JMV2959. JMV2959 administration attenuates FI [61] and ghrelin-induced operant
responding for food reward in rodents [45]. Here, 3V injection of JMV2959 abolished the
ghrelin-induced increases in both appetitive and consummatory behavior at all time points
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examined (Fig. 2.3A-C). Furthermore, 3V JMV2959 + IP saline did not affect FF compared
with 3V saline + IP saline indicating the blockade of FF, FI and FH is not due to non-specific
effects on locomotor activity. The inhibition observed following central GHSR antagonism is in
contrast to previous work with Siberian hamsters attempting to block the appetitive and
consummatory effects of exogenous ghrelin, both directly and indirectly [41, 42, 62, 63], in that
there was a complete blockade of both appetitive and consummatory behaviors throughout the
duration of the experiment. Furthermore, direct 3V administration of JMV2959 circumvents
peripheral GHSR manipulation and therefore directly tests the discrete role of central GHSR
activation. The blockade of appetitive behaviors in response to a peripheral ghrelin challenge
suggests central GHSR activation is integral for these effects and could in turn be a more useful
clinical treatment option if the mechanism for this complete blockade could be discerned. It
remains unclear however the exact ghrelin-dependent pathway being inhibited as 3V
administration of JMV2959 blocks GHSR activation throughout the brain and future studies are
needed to delineate the precise pathways driving appetitive and consummatory behaviors. We
have collectively demonstrated for the first time that central GHSR activation is integral in
driving appetitive and consummatory behaviors in Siberian hamsters.
To further examine the ability of JMV2959 to block ghrelin-induced increases in
appetitive and consummatory behaviors, we chronically injected JMV2959 throughout a 48 h
food deprivation, which has previously been shown to potently increase FF, FI and FH and
circulating ghrelin levels in Siberian hamsters [18, 19, 64-66]. We chose to repeatedly inject
JMV2959 in 12 h increments to block GHSR activation throughout food deprivation in line with
previous experiments [41] because ghrelin is continuously released in response to the negative
energy balance that would occur during the 48 h food deprivation. 3V treatment with JMV2959
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blocked FF and FI through 2 h and FH through 4 h post refeeding (Fig. 2.4A-C). By contrast to
a single peripheral ghrelin challenge, food deprivation chronically increases circulating ghrelin
concentrations. In turn, acute GHSR antagonism is able to block exogenous ghrelin, but not food
deprivation-induced increases in both long-term appetitive and consummatory behaviors. These
data suggest that JMV2959 blocks the effects of ghrelin throughout food deprivation, but once its
effectiveness is diminished the food deprivation-induced circulating ghrelin begins to drive the
appetitive ingestive behaviors. Taken together, Experiment 2 and Experiment 3 demonstrate that
central activation of GHSR is necessary for exogenous ghrelin-induced increases in FF, FI, and
FH, but not for long-term food deprivation-induced increases. This result supports previous
reports suggesting ghrelin is integral in food deprivation increases in appetitive behavior, but not
necessary due to the abundance of other physiological mechanisms compensating in its absence ,
that is the multiple redundant systems driving ingestive behaviors [60, 67].
In order to determine brain areas involved in ghrelin-induced changes in appetitive and
consummatory behaviors in a preliminary examination, c-Fos-ir in the Arc and PVH was
quantified following exogenous ghrelin treatment and 3V administration of JMV2959. We
chose these areas due to previous work indicating significantly increased neuronal activity
following peripheral ghrelin injection [41, 53]. Here, and in previous reports, exogenous ghrelin
potently increased FI and FH 0-4 h post injection [25, 41, 62]. We therefore examined c-Fos-ir
in the Arc and PVH at 2 h following identical treatments as in Experiment 2. Increased c-Fos-ir
in response to exogenous ghrelin was observed in the Arc and PVH 2 h postinjection in line with
previous reports [31, 41, 68]. Pretreatment with JMV2959 blocked neuronal activation in the
PVH following exogenous ghrelin, but, interestingly, the Arc was unaffected (Fig. 2.5A-B).
Approximately 94% of AgRP neurons express GHSRs [69] and exogenous ghrelin markedly
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increases AgRP/NPY expression [70]. Moreover, subthreshold injection of AgRP and NPY
increases FF, FI, and FH in Siberian hamsters [34]. AgRP neurons project to a number of
downstream nuclei including the PVH [35, 71], where it antagonizes melanocortin receptors 3
and 4 (MC3R and MC4R) to promote food intake. In addition, AgRP neurons directly inhibit
neighboring POMC neurons [72, 73]. As GHSR antagonism predominantly affects AgRP
neurons, one potential explanation for our finding is GHSR blockade disinhibits POMC neurons
and in turn, ghrelin-induced c-Fos-ir is comparable in the Arc regardless of GHSR antagonism.
GHSR antagonism may therefore attenuate ghrelin-induced FF, FI, and FH through blockade of
AgRP

PVH neuron signaling, and thereby inhibit PVH c-Fos-ir, while other Arc neurons

remain active. However, as the identity of these c-Fos-positive neurons remains a mystery, we
can only speculate as to the reasoning for this finding.
Ghrelin acts primarily in the Arc to promote food intake [56, 59]; however, GHSRs are
expressed in a number of brain nuclei including the PVH [59]. We hypothesize however that
GHSR blockade attenuates FF, FI, and FH in an Arc-dependent manner based on the following
data: 1) peripheral ghrelin administration markedly increases Arc AgRP expression and these
neurons project to the PVH [53, 72, 74], 2) Complete Arc or NPY neuron ablation markedly
decreases both central and peripheral ghrelin-induced food intake [75, 76] indicating Arc
activation mediates ghrelin-induced food intake, and 3) photostimulation of AgRP neurons
markedly increases food intake [37, 77] whereas concurrent AgRP photostimulation and AgRP
PVH chemoinhibition attenuates this increase [37] indicating AgRP

PVH activation

primarily drives food intake. Collectively, these data indicate the inhibition of PVH neuronal
activity here is due to downstream effects of Arc GHSR blockade. Based on behavioral results
in Experiment 2, we hypothesize that peripheral ghrelin may increase appetitive behaviors in the

47

very least in a PVH-involved mechanism and GHSR blockade attenuates ghrelin-induced
neuronal activity of PVH inputs. It remains unclear, however, if PVH activity is in response to
hindbrain activity (or vice versa), other brain areas, or both and future experiments will expand
on this question. We are aware of the circumstantial evidence provided by c-Fos-ir in that the
absence of neuronal activity in the PVH does not necessarily indicate the absence of activity as
some neurons use other immediate-early genes [40]. We therefore interpret these findings as
being suggestive of a possible PVH involved mechanism driving appetitive behaviors in Siberian
hamsters.
These data collectively indicate central activation of GHSR by exogenous ghrelin
is integral in driving appetitive and consummatory behaviors in Siberian hamsters. In addition,
central GHSR antagonism is able to block food deprivation-induced short term increases in
appetitive behaviors, but not long term due to the continued release of ghrelin (e.g., food
deprivation). The blockade of appetitive behaviors in response to GHSR antagonism and a
peripheral ghrelin challenge appear to involve the PVH which receives projections from a
number of discrete brain areas including the Arc. Although GHSR antagonism successfully
blocked ghrelin-induced increases in appetitive and consummatory behaviors, future studies are
needed to delineate the precise pathways involved.
2.6

Perspective and Significance
Understanding the complex relationship of central integration of peripheral satiety

signals is an important step in the development of clinically useful obesity treatment options.
We have developed a novel model to study human food foraging and food hoarding, a relatively
unstudied facet of obesity, in Siberian hamsters. Here, we show for the first time central
blockade of GHSRs prevents the marked increase in both short-term and long-term food
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foraging, food hoarding, and food intake following a peripheral ghrelin challenge. In addition,
we show for the first time this blockade prevents neuronal activation of the PVH, but not the
Arc, suggesting PVH activity is integral in driving both appetitive and consummatory behaviors.
2.7
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3

AGRP KNOCKDOWN BLOCKS LONG-TERM APPETITIVE, BUT NOT
CONSUMMATORY, FEEDING BEHAVIORS IN SIBERIAN HAMSTERS

3.1

Abstract
Arcuate hypothalamus-derived agouti-related protein (AgRP) and neuropeptide Y (NPY)

are critical for maintaining energy homeostasis. Fasting markedly upregulates AgRP/NPY
expression and circulating ghrelin, and exogenous ghrelin treatment robustly increases acute
food foraging and food intake, and chronic food hoarding behaviors in Siberian hamsters. We
previously demonstrated that 3rd ventricular AgRP injection robustly stimulates acute and
chronic food hoarding, largely independent of food foraging and intake. By contrast, 3rd
ventricular NPY injection increases food foraging, food intake, and food hoarding, but this effect
is transient and gone by 24 h post-injection. Because of this discrepancy in AgRP/NPY-induced
ingestive behaviors, we tested whether selective knockdown of AgRP blocks fasting and ghrelininduced increases in food hoarding. AgRP gene knockdown by a novel DICER small interfering
RNA (AgRP-DsiRNA) blocked food-deprivation induced increases in AgRP expression, but had
no effect on NPY expression. AgRP-DsiRNA attenuated acute (1 day), and significantly
decreased chronic (4-6 days), food deprivation-induced increases in food hoarding. In addition,
AgRP-DsiRNA treatment blocked exogenous ghrelin-induced increases in food hoarding
through day 3, but had no effect on basal food foraging, food intake, or food hoarding prior to
ghrelin treatment. Lastly, chronic AgRP knockdown had no effect on body mass, fat mass, or
lean mass in either food deprived or ad libitum fed hamsters. These data collectively suggest
that the prolonged increase in food hoarding behavior following energetic challenges, and food
deprivation especially, is primarily regulated by downstream AgRP signaling.
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3.2

Introduction
Obesity is a critical health concern facing both developed and developing countries

worldwide due to its many secondary comorbidities including stroke, type 2 diabetes,
cardiovascular disease, and cancer [1-5]. Energy intake that exceeds energy expenditure is the
primary cause of obesity, and the prevalence of readily accessible, calorically dense foods
contributes to a state of chronic energy surplus in obese persons [6]. Previous research on
ingestive behaviors has largely focused on uncovering the neuroendocrine mechanisms
governing food intake using laboratory mice and rats, yet in humans the search for food (i.e. food
shopping/foraging) invariably precedes the immediate consumption or long-term storage (i.e. in
refrigerators, freezers, and pantries) or hoarding of food. Hence, ingestive behaviors are more
accurately dichotomized as appetitive behaviors that bring animals into contact with food (i.e.
food foraging and food hoarding) and consummatory behaviors in which animals consume food
[7]. Previous studies have suggested obese or food deprived persons purchase more calorically
dense, high-fat foods and hoard these items for longer periods of time relative to lean or satiated
persons [8-11]. In turn, elucidating the mechanisms mediating ingestive behaviors as a whole
represents a novel approach for the development of obesity reversal or prevention options.
To investigate the central nuclei regulating appetitive (i.e. food foraging and hoarding)
and consummatory (i.e. food intake) ingestive behaviors necessitates an animal model that
naturally hoards food. Siberian hamsters (Phodopus sungorus), like humans, are natural and
prodigious food hoarders [12], and we have previously shown that energetic challenges (e.g.
food deprivation and ghrelin) robustly increase this behavior [12-14]. We have developed a
unique experimental approach to test the central and peripheral factors regulating ingestive
behaviors by which animals earn food through wheel running in a top “foraging” cage, and store
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this food for future meals in a bottom “hoarding” cage [15]. With this experimental set up, we
have begun to elucidate the complex neuroendocrine network mediating these appetitive and
consummatory ingestive behaviors (for review see [6]).
The stomach-derived orexigenic hormone ghrelin is of particular interest in the context of
ingestive behaviors due to its preprandial rise and postprandial decrease [16-18]. Exogenous
ghrelin treatment, mimicking an energy deplete state, markedly increases ingestive behaviors in
humans and laboratory rodents including Siberian hamsters [19-22]. We have recently shown
that third ventricular or intraperitoneal exogenous ghrelin treatment acutely increases food intake
and food foraging (~2-4 h), and drives chronic (~5-7 days) food hoarding increases, both of
which are blocked by central ghrelin receptor antagonism [23]. The ghrelin receptor (growth
hormone secretagogue receptor 1a [GHSR]) is broadly distributed in the brain [24, 25], including
on hypothalamic arcuate nucleus (Arc) neurons that coexpress agouti-related protein (AgRP),
neuropeptide Y (NPY), and gamma-aminobutyric acid (GABA)- termed AgRP neurons as AgRP
is spatially limited to the Arc [25, 26]. The Arc contains receptors for numerous circulating
endocrine signals (e.g. ghrelin and leptin), and exogenous ghrelin treatment robustly increases
AgRP/NPY expression [27, 28]. A critical role of these neurons in regulating energy
homeostasis is further supported by the finding that ablation of these neurons in adult mice
results in profound hypophagia [29]. In addition, AgRP neurons regulate ingestive behaviors
through temporally discrete mechanisms. Pharmacogenetic or optogenetic AgRP neuron
activation drives rapid, NPY/GABA-dependent food intake, and delayed, but prolonged, AgRPdependent food intake in mice [30]. Although AgRP and NPY are sufficient to mediate food
intake through distinct temporal mechanisms, it remains unclear if these neuropeptides regulate
acute and chronic food foraging and food hoarding through similar mechanisms. To this end, we
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recently demonstrated that central NPY administration markedly increases food foraging, food
hoarding, and food intake in Siberian hamsters, but this effect is transient and gone by 24 h postinjection [31]. ICV blockade of the NPY Y1 receptor completely blocks fasting- and ghrelininduced food foraging and food intake, but has comparatively little effect on food hoarding,
suggesting either other NPY receptors or neurochemical systems mediate this behavior [32]. In
support of an NPY-independent mechanism regulating multi-day food hoarding following
energetic challenges, we found that central AgRP robustly increases both acute and chronic
(through 7 days) food hoarding to a much greater extent than food foraging or food intake in
Siberian hamsters [33]. These findings collectively suggest the presence of separate
neurochemical mechanisms regulating appetitive and consummatory behaviors following
energetic challenges, and that this differential neuropeptide regulation of ingestive behaviors
occurs through temporally discrete mechanisms such that acute changes in consummatory
behavior are not intrinsically followed by changes in appetitive behaviors. We therefore tested
whether AgRP discretely regulates food deprivation- or ghrelin-induced appetitive and
consummatory ingestive behavior, including food intake, foraging, and hoarding.
To test the necessity of AgRP in regulating food deprivation- and ghrelin-induced
increases in ingestive behaviors necessitates a novel approach that specifically targets AgRP.
The development of DICER small interfering RNA (DsiRNA) duplexes and other antisense
oligonucleotides has facilitated in vivo, targeted mRNA knockdown in non-genetically
engineered animals including humans (for review see [34]). AgRP-DsiRNA mediated gene
knockdown circumvents the inherent confounds of germ-line knockout models or non-specific
receptor antagonism, and affords the ability to directly test the endogenous function of AgRP in a
natural animal model of food hoarding. Here, we tested the role of AgRP in the regulation of
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ingestive behaviors by giving chronic AgRP-DsiRNA injections throughout energetic challenges
in Siberian hamsters housed in our foraging and hoarding system. In addition, we have used a
protocol modified from our previous studies, which enables us to more accurately examine the
effects of AgRP knockdown on ingestive behaviors at discrete time points.
3.3

Materials and Methods

3.3.1 Animals
Adult male Siberian hamsters aged ~2 months and weighing 30-40 g were obtained from
our breeding colony as previously described [35]. Hamsters were sexed and group housed from
birth in a summer-like photoperiod (16:8-h light-dark cycle, light offset at 1900) with ad libitum
access to food (formula 5001, Purina, St. Louis, MO) and water. Room temperature was
maintained at 21.0 ± 2ᵒC. All procedures were approved by the Georgia State University
Institutional Animal Care and Use Committee and were in compliance with the Public Health
Service and United States Department of Agriculture guidelines
3.3.2 RNAi-mediated gene knockdown
To specifically knockdown Arc AgRP, we chose a DICER small interfering RNA
(DsiRNA) directed against AgRP (MMC.RNAI.N007427.12.1; Integrated DNA Technologies
[AgRP-DsiRNA]) and a control scrambled RNA (DsiRNA; NC1; Integrated DNA Technologies
[scRNA]) directed against no known mRNA sequence. scRNA and AgRP-DsiRNA were
initially reconstituted in sterile dH2O, aliquoted, and frozen at -80°C to prevent RNA
degradation. For hydrodynamic injections, scRNA (0.4µg/g body mass [BM]) and AgRPDsiRNA (0.4µg/g BM) were diluted in sterile saline and rapidly injected intraperitoneally (i.p.)
as previously described [36-38].
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3.3.3 Blood brain barrier permeability and central effects of DsiRNA-mediated AgRP
knockdown
Blood brain barrier permeability was tested using peripheral sodium fluorescein
injections (10%, 5ml/kg, i.p.; Sigma-Aldrich). Following a single i.p. injection, animals were
returned to their home cage for 30 min and then killed by an overdose of Fatal Plus (300 mg/kg,
i.p.; Vortech Pharmaceuticals). Animals were transcardially perfused with 10 ml ice cold 0.1 M
PBS followed by 30 ml ice cold 4.0% paraformaldehyde in 0.1 M PBS. Brains were then
extracted and transferred to 4.0% paraformaldehyde in 0.1 M PBS overnight and then 18.0%
sucrose at 4°C. Brains were subsequently sectioned with a cryostat at 20 µm and the Arc
immediately visualized with fluorescent microscopy.
To test the efficacy of AgRP-DsiRNA-mediated gene knockdown, we chose a 48 h food
deprivation challenge as this energetic challenge typically causes a marked increase of AgRP and
NPY expression in Siberian hamsters [39, 40]. Preliminary experiments indicated daily AgRPDsiRNA (0.4µg/g BM i.p.) injections most effectively blocked AgRP mRNA expression (data
not shown), so we adopted this approach for all subsequent experiments [Fig. 1A]. In one cohort
of hamsters used for in situ hybridization, animals were food deprived for 48 h and given either
scRNA (0.4µg/g BM i.p.) or AgRP-DsiRNA (0.4µg/g BM i.p.) daily at 0900 (two total injections
at t=0 and t + 24 h). Animals were killed by an overdose of Fatal Plus 48 h after food removal
(i.e. 24 h after the last injection), and then transcardially perfused with 75 ml of heparinized
0.9% NaCl in RNase free 0.01% diethylpyrocarbonate (DEPC)-treated dH2O followed by 150 ml
4.0% paraformaldehyde in 0.1 M PBS in sterile filtered dH2O. Brains were subsequently
removed, post fixed in sterile 4.0% paraformaldehyde in 0.1 M PBS overnight, and then
transferred to sterile 0.01% DEPC-treated 18.0% sucrose at 4°C. Brains were sectioned with a
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cryostat at 20 µm in series across 3 slides to cover the entirety of the Arc, and then frozen at 80°C to reduce mRNA degradation.
In a separate cohort of hamsters used for quantitative PCR (qPCR) analysis, animals were
either food deprived or allowed ad libitum access to food. Food deprived and ad libitum fed
animals were given either scrambled RNA (scRNA) or AgRP-DsiRNA (0.4µg/g BM i.p.)
injections daily at 0900 across 48 h (two total injections at t=0 and t + 24 h). Animals were
killed by rapid decapitation 24 h later (i.e. t + 48 h), the brain extracted, and 1 mm sagittal
sections taken from both sides of the midline. The hypothalamus was identified and cut rostrally
at the optic chiasm, caudally at the mammillary bodies, and a ~0.5 mm dorsal cut made to isolate
the Arc which was immediately flash frozen in liquid nitrogen. Frozen hypothalamic tissue was
stored at -80°C until processing to reduce mRNA degradation. Importantly, qPCR analysis was
repeated in three separate cohorts of animals to ensure consistent results and a robust
physiological effect of the AgRP-DsiRNA.
3.3.4 Fluorescent in situ hybridization for AgRP and NPY mRNA
We used double-fluorescent in situ hybridization to analyze both AgRP and NPY
expression following a 48 h food deprivation challenge and treatment with either scRNA or
AgRP-DsiRNA as previously described [40, 41]. In brief, single-stranded antisense mRNA
fragments against rat AgRP (a generous gift from Dr. Kevin Grove) and hamster NPY (provided
by S. Chua, Columbia University, New York, NY) were reverse transcribed from plasmid DNA
and labeled with digoxigenin (DIG RNA Labeling Mix; Roche Applied Sciences) or FITC (FITC
RNA Labeling Mix; Roche Applied Sciences). A rat antisense AgRP riboprobe was used as
previously described [42] because of its consistently robust, specific staining. Frozen slides
containing the mounted sections were removed from -80°C ~20 min before use to reach room
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temperature. Slides were submerged in 2x SSC, acetylated with 0.1 M triethanolamine/0.25%
acetic anhydride solution in 0.1% DEPC-treated dH2O, and then fixed the tissues with a 1:1
acetone/methanol mixture. We next added 150 µl prehybridization buffer, coverslipped the
slides, and left the sections at room temperature for 30 min. Coverslips were then removed and
tissues hybridized with antisense riboprobes (150 ng/slide) for AgRP and NPY in a humid
chamber for 16-20 h at 58°C. Slides were subsequently removed from humid chambers and
submerged in an RNase A/ 2x SSC solution (20µg/ml) at 37°C to degrade unbound RNA.
Sections were washed in decreasing 2x SSC concentrations to 0.5x, quenched for endogenous
peroxidase activity with 1.0% H2O2, and permeabilized with 0.5% Tween 20 in 0.1 M Tris-HCL.
Sections were then blocked in 10% normal sheep serum (NshS) and 5.0% casein in 0.1 M trisbuffered saline (TBS) for 30 min. We next incubated the sections with sheep anti-digoxigenin
FAB fragments (1:250; Roche Applied Sciences) in 10.0% NShS and 5.0% casein in 0.1 M TBS
for 2 h at room temperature and amplified the signal with tyramide signal amplification (TSA;
1:200; TSA Plus Cyanine 3 Kit; PerkinElmer Lifer and Analytical Sciences). To amplify and
reveal the second (FITC) riboprobe, we used a second peroxidase quenching step with 3% H2O2
in 0.1 M TBS, blocked the sections for 30 min in 10% NShS and 5.0% casein, and then
incubated the sections for 2 h at room temperature with anti-FITC FAB fragments (1:250; Roche
Applied Sciences) that were subsequently amplified via TSA (1:200; TSA Plus Fluorescein;
PerkinElmer Life and Analytical Sciences). Slides were coverslipped with Prolong antifade
fluorescent medium (Invitrogen) and stored at room temperature, shielded from light, until image
capture.
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3.3.5 Fluorescent quantification
Fluorescent labeling in the Arc was quantified with experimenters blind to treatment
conditions. A mouse brain atlas (Paxinos and Franklin [43]) was used as it most closely matches
the Siberian hamster brain and no Siberian hamster brain atlas exists. Total cells expressing
NPY and AgRP were counted across the Arc in each animal and then averaged for each
treatment group. Relative fluorescent intensity (RFI) was measured for each mRNA probe for
all animals as previously described [40, 44]. In brief, background was normalized for all
sections and NIH ImageJ software was used to capture and measure fluorescent intensity of a
defined Arc region. Intensity measurements of either AgRP or NPY were then averaged across
all animals for each treatment group.
3.3.6 Quantitative PCR analysis
RNA from frozen hypothalamic tissue was extracted using TRIzol Reagent (Thermo
Fisher) and subsequently reverse transcribed into cDNA with a High-Capacity cDNA Reverse
Transcription Kit (Thermo Fisher) according to the manufacturer’s instructions. AgRP and NPY
gene expression was measured using TaqMan Gene Expression Master Mix (Thermo Fisher) and
a 7500-Fast RT-PCR machine (Applied Biosystems). As Siberian hamster TaqMan primers and
probes are not commercially available, custom primer/probe sets were generated (Applied
Biosystems) based on previously described Siberian hamster AgRP and NPY sequences [45].
AgRP primers/probe- forward primer: AGGCCCTGCTGCAGAAG, reverse primer:
GACTCGCGATTCTGTGGATCTAG, reporter probe: ACCTCCGCCAACGCT; NPY
primers/probe- forward primer: CTCCGCTGGTGCATCCT, reverse primer:
GTGCTGGCTGAGGGATACC, reporter probe: AAGCCTGACAATCCTG. Mouse
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Applied Biosystems) was used as an
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endogenous control as its expression was consistent across all animals and treatments (A.T. and
T.J.B. unpublished observations).
3.3.7 Foraging and hoarding apparatus
At the start of the experiment, animals were transferred to the foraging/hoarding room
and singly housed in polypropylene cages (27.8 X 17.5 X 13.0 cm) with Alpha-dri bedding
(Specialty Papers, Kalamazoo, MI) and a single cotton Nestlet (Ancare, Belmore, NY). Animals
were allowed ad libitum access to the experimental diet (purified 75-mg Dustless Precision
Pellets, Bio-Serve, Frenchtown, NJ) and water, and given two weeks to acclimate to the new
light cycle (16:8-h light-dark cycle, light offset at 1200). Following acclimation to the new
photoperiod, animals were transferred to our foraging and hoarding apparatus, modified from
Perrigio and Bronson [46], as previously described [15]. In brief, animals were given
unrestrained access to a top “foraging” cage (456 mm long × 234 mm wide × 200 mm high)
equipped with a running wheel, pellet dispenser, and water bottle, and a bottom “hoarding” cage
(290 mm long × 180 mm wide × 130 mm high) containing Alpha-Dri bedding and one cotton
nestlet. The foraging and hoarding cages were connected by convoluted polyvinylchloride
tubing (38.1 mm inner diameter, ~1.5 m long) with bends and runs to facilitate movement
between the two cages. Animals were allowed a two-week training period to the foraging and
hoarding apparatus before experimental manipulation. During the first two days of this training
period, animals were given free access to food pellets and were able to earn an additional pellet
by completing 10 wheel revolutions. Following this two-day period, free access to food was
removed and all food had to be earned through wheel running (1 pellet/10 wheel revolutions),
during which time wheel revolutions, pellets earned, food intake, and food hoarding were
measured daily.
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3.3.8 Measurement of food foraging, food hoarding, and food intake experimental protocol
For all behavioral experiments, food foraging, food hoarding, and food intake was
assessed daily at 0900. Food foraging was defined as the number of wheel revolutions divided
by 10, as 10 revolutions were required for each pellet delivery. Food hoarding was defined as
the number of pellets present in the bottom hoarding cage in addition to pellets removed from the
cheek pouches of hamsters. Food intake was defined as [the number of pellets earned – (number
of pellets remaining in the top cage that were not hoarded + number of pellets hoarded)]. All
food pellets were weighed on an electronic scale set to “parts” measurement with one 75 mg
food pellet= 1, and fractions of pellets calculated as well.
3.3.8.1 Experiment 1: Does AgRP-DsiRNA block food deprivation-induced increases in
appetitive behaviors?
At the end of the training period, animals were divided into two groups counterbalanced
for BM, food foraging, food hoarding, and food intake: 1) scRNA (0.4µg/g BM i.p.); 2) AgRPDsiRNA (0.4µg/g BM i.p.). At the start of the food deprivation challenge, animals were
transferred to a new hoarding cage, provided water, and blocked in this cage to prevent access to
the top foraging cage for 48 h. At the conclusion of the 48 h food deprivation, animals were
unblocked from the hoarding cage at lights off (1200) and allowed access to the foraging cage.
scRNA or AgRP-DsiRNA injections were given daily (at 0900) throughout the food deprivation,
and then daily at the same time as data collection (0900) throughout the duration of the
experiment for a total of 8 injections (i.e. 2 days of food deprivation and 6 total days of post-fast
refeeding behavioral data collection) [Fig. 1B].
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3.3.8.2 Experiment 2: Does AgRP-DsiRNA block Ghrelin-induced increases in appetitive
behaviors?
Following the training period in a separate cohort of hamsters, animals were divided into
four groups counterbalanced for BM, food foraging, food hoarding, and food intake: 1) i.p. saline
+ scRNA (0.4µg/g BM i.p.); 2) i.p. ghrelin (30 µg/kg BM i.p.) + scRNA (0.4µg/g BM i.p.); 3)
i.p. ghrelin (30 µg/kg BM i.p.) + AgRP-DsiRNA (0.4µg/g BM i.p.); 4) i.p. saline + AgRPDsiRNA (0.4µg/g BM i.p.). To ensure adequate AgRP knockdown, animals received either
scRNA or AgRP-DsiRNA injections (at 0900) for two days prior to ghrelin injection. On
experimental test day, food was removed from the top foraging cage and animals were placed
into a new, clean hoarding cage immediately following AgRP-DsiRNA injections. Animals were
blocked in this cage at 0900 to prevent wheel running, food intake, or food hoarding prior to
ghrelin injection at lights off at 1200 as previously described [22, 23]. Immediately after lights
off, animals were injected with either saline or ghrelin and cages were unblocked to allow for
access to the top cage. On subsequent days, animals were given either scRNA or AgRPDsiRNA injections at the same time as data collection for the duration of the experiment (0900).
Hence, animals received a total of 9 injections throughout the experiment (i.e. 2 days prior to
ghrelin injection, the morning of ghrelin injection, and 6 days of post-ghrelin behavioral data
collection) [Fig. 1C].
3.3.9 Body composition measurements
Body composition measurements for experiment 1 and experiment 2 hamsters were taken
using our Minispec LF90 TD-NMR analyzer (Bruker Optics). For all measurements, animals
were briefly removed from their home cage, placed in the body composition analyzer, and then
immediately returned to their home cage. Body composition measurements were taken for all
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animals prior to the start of experiment 1 and experiment 2, and then again at the conclusion of
the experiments.
3.3.10 Statistical analysis
All data are expressed as mean ± S.E. Relative AgRP and NPY gene expression as
measured by quantitative PCR were normalized to GAPDH. For behavioral experiments, data
for each animal on experiment day(s) (i.e., number of pellets earned, consumed, or hoarded)
were compared with the average data across the three days prior to the experiment start (i.e.
baseline values) for the same animal. For a subset of statistical analyses where percent baseline
(% baseline) was used, % baseline for each animal on experimental day(s) was calculated as
given by the formula [(animal X on experimental day(s)/animal X baseline)*100] and compared
with that animals normalized baseline value as given by the formula [(animal X baseline/average
for all animals in the group)*100]. Data were analyzed by a Student’s t-test, Mann-Whitney U
test, or a one-way or two-way ANOVA followed by Duncan’s Multiple-Comparison post-hoc
analysis where appropriate. For all experiments, differences among groups was considered
statistically significant at P<0.05 and trending toward significance at P<0.1.
3.4

Results

3.4.1 AgRP-DsiRNA blocks food deprivation-induced Arc AgRP expression
i.p. sodium fluorescein injections revealed extensive neuronal labeling within the Arc, but
not in nearby hypothalamic nuclei including the ventromedial hypothalamus (VMH) or
dorsomedial hypothalamus (DMH) [Fig. 3.2A], indicating that peripherally administered drugs
are sufficient to reach Arc neurons. We therefore sought to test whether i.p. administered AgRPDsiRNA was sufficient to block AgRP, but not NPY, expression following an energetic
challenge that typically causes marked increases in AgRP and NPY expression in Siberian
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hamsters [40]. We initially used in situ hybridization against AgRP and NPY mRNA to
visualize mRNA expression following a 48 h fast, and measured relative fluorescent intensity
and neuronal number as markers for AgRP and NPY activation [Fig. 3.1A]. We observed
extensive AgRP and NPY mRNA expression in scrambled RNA (scRNA) treated animals [Fig.
3.2, B-D], but a marked decrease in AgRP, but not NPY, mRNA expression in AgRP-DsiRNA
treated animals [Fig. 3.2, E-G]. Relative fluorescent intensity quantification revealed AgRPDsiRNA significantly decreased AgRP mRNA expression by approximately 50% [P<0.05; Fig.
3.2H], but had no effect on NPY mRNA Expression [Fig. 3.2I]. In addition, the number of
AgRP-positive neurons was significantly decreased in AgRP-DsiRNA treated animals compared
with scRNA treatment [P<0.05; Fig. 3.2J], but there was no effect on NPY-positive neurons
[Fig. 3.2J].
To confirm our in situ data, and to further validate the efficacy of AgRP-DsiRNA, we
repeated the 48 h food deprivation challenge in a separate cohort of animals and measured AgRP
and NPY mRNA expression with quantitative PCR (qPCR). AgRP-DsiRNA significantly
decreased AgRP mRNA expression in ad libitum fed animals compared with scRNA treated
animals [P<0.05; Fig. 3.3A]. Moreover, 48 h food deprivation significantly increased AgRP
mRNA expression in scRNA treated animals, but this effect was abrogated by AgRP-DsiRNA
treatment [P<0.05; Fig. 3.3A]. By contrast to AgRP mRNA expression, AgRP-DsiRNA
treatment had no effect on NPY mRNA expression in either ad libitum fed animals or 48 h food
deprived animals compared with control scRNA treated animals [Fig. 3.3B].
3.4.2 AgRP-DsiRNA attenuates food deprivation-induced food hoarding
After confirming the efficacy of AgRP-DsiRNA, we tested whether AgRP knockdown
affects food foraging, food intake, or food hoarding following a food deprivation challenge [Fig.
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3.1B]. Upon refeeding after a 48 h fast, the number of pellets earned was significantly decreased
in both scRNA and AgRP-DsiRNA treated animals relative to baseline, and this marked decrease
in foraging effort failed to return to baseline levels throughout the experiment [P<0.05; Fig.
3.4A]. In addition, a trend of increased pellets earned (foraging) was observed in AgRPDsiRNA treated animals compared with scRNA treatment at day 1 [P<0.1; Fig. 3.4A].
However, we observed no difference in foraging effort between treatment groups at days 2-6
post-refeeding. Food intake was significantly decreased at day 1 and day 2 post-refeeding for
both scRNA and AgRP-DsiRNA treated animals relative to baseline [P<0.05; Fig. 3.4B], but
AgRP-DsiRNA had no effect on pellets consumed compared with scRNA treatment at any time
point examined [Fig. 3.4B]. By contrast, food hoarding was markedly increased relative to
baseline for both AgRP-DsiRNA and scRNA treated animals on days 1 and 2 post-refeeding
[P<0.05; Fig. 3.4C], but AgRP knockdown blocked this relative increase at day 4. Moreover,
AgRP-DsiRNA significantly decreased food hoarding at days 1 and 4 post-refeeding compared
with scRNA treated animals [P<0.05; Fig. 3.4C], and a trend of decreased food hoarding was
observed at day 5 post-refeeding [P=0.1; Fig. 3.4C].
Because we previously found central AgRP increases food hoarding across multiple days
[33], we combined the total number of pellets earned, consumed, or hoarded across days 2-3 and
4-6 post-refeeding (Fig. 3.4D-F) to identify changes in behavioral trends that may not otherwise
be apparent when discretely examining each day as previously described [40]. Of note, we
omitted day 1 from our analysis of combined days 2-3 as the data at this time point were
markedly different from ensuing time points and tended to skew the data on these days. Despite
the trend of decreased food foraging at day 1 post-refeeding [P<0.1; Fig. 3.4D], we found no
difference in foraging effort on days 2-3 or 4-6 [Fig. 3.4D]. In addition, AgRP-DsiRNA
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treatment had no effect on food intake on either day 1 post-refeeding, or on combined days 2-3
or 4-6 [Fig. 3.4E]. By contrast to food foraging and food intake, AgRP-DsiRNA treatment
significantly decreased pellets hoarded at day 1 post refeeding [P<0.05; Fig. 3.4F], and a trend
of decreased pellets hoarded was observed on combined days 4-6 compared with scRNA treated
animals [P=0.054; Fig. 3.4F].
We next converted raw food foraging, food intake, and food hoarding values into
percentage of baseline (% baseline) (Fig. 3.4G-I) to compare the effects of AgRP-DsiRNA on
ingestive behaviors in an energy deplete state with an ad lib-fed condition. Food deprivation
markedly decreased food foraging in both AgRP-DsiRNA and scRNA treated animals compared
with baseline on day 1 post-refeeding and for combined days 2-3 and 4-6, and never returned
above ~80% baseline levels [P<0.05; Fig. 3.4G]. AgRP-DsiRNA treatment tended to increase
pellets earned on day 1 post-refeeding compared with control animals [P<0.1; Fig. 4G], which
reached statistical significance on combined days 2-3 [P<0.05; Fig. 3.4G]. Food deprivation
significantly decreased food intake relative to baseline in both AgRP-DsiRNA and scRNA
treated animals on day 1 and combined days 2-3 post-refeeding [P<0.05; Fig. 3.4H], with the
food intake returned to baseline values on combined days 4-6 post-refeeding [Fig. 3.4H].
However, no difference in food intake was observed between treatments at any time point
examined. By contrast to the marked decrease in food foraging and food intake, food
deprivation robustly increased food hoarding relative to baseline at day 1 post-refeeding, and
remained increased over baseline on days 2-3 and 4-6 post-refeeding in scRNA treated hamsters
[P<0.05; Fig. 3.4I]. AgRP-DsiRNA treatment significantly decreased food hoarding by ~50%
on day 1 post-refeeding compared with control animals [P<0.05; Fig. 3.4I], and attenuated this
increase on days 4-6 [P<0.05; Fig. 3.4I].

72

48 h food deprivation resulted in a profound ~20% decrease in body mass in both scRNA
and AgRP-DsiRNA treated animals, and this change in body mass remained significantly
decreased relative to baseline in both groups for the duration of the experiment [P<0.05; Fig.
3.5A]. Moreover, food deprivation significantly decreased % fat mass and increased % lean
mass relative to baseline for both AgRP-DsiRNA and scRNA treated animals [P<0.05; Fig. 3.5B
and 3.5C], but we found no differences in % fat mass or % lean mass at any time point between
these groups (Fig. 3.5B and 3.5C).
3.4.3 AgRP-DsiRNA attenuates ghrelin-induced food hoarding
Because food deprivation markedly increases circulating ghrelin, we next tested whether
AgRP mRNA knockdown is sufficient to block ghrelin-induced ingestive behaviors [Fig. 3.1C].
AgRP-DsiRNA treatment had no effect on pellets earned, consumed, or hoarded prior to the
exogenous ghrelin treatment when compared with baseline values [Fig. 3.6A-C]. However, we
found a significant decrease in foraging effort for all groups on day 1 following exogenous
ghrelin [P <0.05; Fig. 3.6A], an effect likely stemming from the novelty of the experimental
procedure as ghrelin injections occurred at lights off (1200) on the preceding day and pre-ghrelin
scRNA or AgRP-DsiRNA injections (at 0900) had no effect on behavior arguing against a
possible pain response. Subsequent to this initial decrease in food foraging, we found no
differences in food foraging for the remainder of the experiment nor food intake at any time
point examined for all groups following exogenous ghrelin [Fig. 3.6A and 3.6B]. By contrast,
systemic ghrelin significantly increased food hoarding compared with control saline + scRNA
treated animals at day 1 post-injection [P<0.05; Fig. 3.6C], and AgRP-DsiRNA treatment
attenuated this increase. We found no subsequent differences in the number of pellets hoarded
among any group on days 2-6 post-injection [Fig. 3.6C].
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We next combined the raw pellets foraged for, consumed, or hoarded on days 1-3 and 4-6
(Fig. 3.6D-F) and then converted these values into a percent change from baseline (Fig. 6G-I) to
identify any cumulative effects of exogenous ghrelin or AgRP-DsiRNA on behavior. We found
no difference between any group in the absolute number of pellets earned [Fig. 3.6D], consumed
[Fig. 3.6E], or hoarded [Fig. 3.6F] on either combined days 1-3 or 4-6. By contrast, we found a
significant decrease in pellets earned relative to baseline for all groups on days 1-3 post injection
[Fig. 3.6G], most likely stemming from the novelty of the procedure. Although exogenous
ghrelin had no effect on food foraging in combined days 1-3, we found a significant increase
compared with scRNA treated animals on days 4-6, and this effect was attenuated with AgRPDsiRNA treatment [P<0.05; Fig. 3.6G]. In line with our food deprivation data, exogenous
ghrelin significantly decreased food intake during combined days 1-3 relative to baseline in
ghrelin + scRNA, but this effect was absent in AgRP-DsiRNA treated animals [P<0.05; Fig.
3.6H]. Moreover, saline + AgRP-DsiRNA treatment significantly increased pellets consumed
compared with saline + scRNA and ghrelin + scRNA treatment on combined days 1-3 and 4-6
[P<0.05; Fig. 3.6H]. Ghrelin + AgRP-DsiRNA treatment also significantly increased pellets
consumed compared with ghrelin + scRNA treatment on combined days 1-3 [P<0.05; Fig. 3.6H].
As expected, exogenous ghrelin robustly and significantly increased food hoarding relative to
baseline on days 1-3 post-injection compared with all other groups [P<0.05; Fig. 3.6I]. Of note,
we found no change in food hoarding in AgRP-DsiRNA treated animals compared with baseline
or scRNA control animals, indicating AgRP knockdown specifically abrogated ghrelin-induced
hoarding behavior. No subsequent change in food hoarding was observed in any group on
combined days 4-6 post-injection [Fig. 3.6I].
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Concurrent with our behavior experiment, we measured body mass and body composition
to uncover any effects of AgRP-DsiRNA on body mass, % fat mass, or % lean mass across time.
We found no difference in body mass change across time, or in % fat mass or % lean mass at
either baseline or at the conclusion of the experiment [Fig. 3.7A-C].
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Fig. 3.1 Experimental timeline.
Experimental timeline for AgRP-DsiRNA (0.4µg/g BM i.p.) in situ hybridization and
quantitative PCR efficacy tests (A). Experimental timelines for training, AgRP-DsiRNA
(0.4µg/g BM i.p.) or scRNA (0.4µg/g BM i.p.) treatment, and data collection for
behavioral Experiment 1 (B) or behavioral Experiment 2 (C).
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Fig. 3.2 AgRP-DsiRNA selectively blocks AgRP expression.
Representative image of arcuate nucleus neuronal labeling following sodium fluorescein
injections (10%, 5ml/kg, i.p) (A). Representative double-fluorescent in situ hybridization
images for AgRP (green), NPY (red), and merged sections in scRNA (0.4µg/g BM i.p.)
(B-D) and AgRP-DsiRNA (0.4µg/g BM i.p.) treated (E-G) animals. Relative fluorescent
intensity (RFI) measurements for AgRP (H) and NPY (I) (n=4-5 per group). Average
number of arcuate nucleus AgRP-positive and NPY-positive neurons in AgRP-DsiRNA
and scRNA treated animals (J) (n=4-5 per group). Scale bar in A-G= 100 µm. Data
reported as mean ± S.E.M. *P<0.05 vs. scRNA treatment.
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Fig. 3.3 AgRP-DsiRNA blocks food deprivation-induced AgRP increases.
Relative arcuate nucleus AgRP (A) and NPY (B) mRNA expression as measured by qPCR
in ad libitum fed and food deprived animals receiving either scRNA (0.4µg/g BM i.p.) or
AgRP-DsiRNA (0.4µg/g BM i.p.) (n=8-15 per group). Data are averages across three
experimental cohorts. Data reported as mean ± S.E.M. Values that do not share a
common superscript are significantly different at P<0.05.
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Fig. 3.4 AgRP knockdown attenuates food deprivation-induced food hoarding.
Average number of pellets earned (A), consumed (B), and hoarded (C) prior to food
removal (baseline) and upon refeeding after a 48 h food deprivation challenge in scRNA
(0.4µg/g BM i.p.) and AgRP-DsiRNA (0.4µg/g BM i.p.) treated animals. Day 1 and
combined days 2-3 and 4-6 number of pellets earned (D), consumed (E), and hoarded (F)
following refeeding. Percent baseline converted pellets earned (G), pellets consumed
(H), and pellets hoarded (I) for day 1 and combined days 2-3 and 4-6. n= 19-20 per
group. (A-C), baseline values were calculated as the 3 day pellet average prior to
experimental start time. (G-I), baseline (i.e. 100%) was calculated for each animal using
the formula [(3 day animal baseline average/ average of all animals in the group)*100]
when comparing day 1, [((3 day animal baseline average*2)/ average of all animals in the
group)*100] when comparing days 2-3, or [((3 day animal baseline average*3)/ average
of all animals in the group)*100] when comparing days 4-6. Data reported as mean ±
S.E.M. aP<0.05 vs. AgRP-DsiRNA treated animals; *P<0.05 vs. baseline.
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Number of pellets earned (A), consumed (B), and hoarded (C) prior to injections
(baseline) and in response to saline + scRNA (0.4µg/g BM i.p.), ghrelin (30µg/kg i.p.) +
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experimental start time. (G-I), baseline (i.e. 100%) was calculated for each animal using
the formula [((3 day animal baseline average*3)/ average of all animals in the
group)*100]. Data reported as mean ± S.E.M. aP<0.05 vs. saline + scRNA treatment;
b
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3.5

Discussion
Given the multitude of pharmacological studies by us and others implicating discrete

functional and temporal roles of AgRP and NPY in regulating ingestive behaviors [30, 31, 33],
we tested here for the first time if AgRP knockdown affects food hoarding following energetic
challenges. We initially confirmed that peripherally administered substances, and thus antisense
oligos, are sufficient to reach the Arc and, in turn, circumvents the need for central cannulations
and drug delivery. By employing a novel AgRP-DsiRNA, we were able to attenuate food
deprivation-induced increases in AgRP mRNA expression and decrease basal AgRP expression
in ad libitum fed hamsters without affecting NPY mRNA expression. We chose to test the
efficacy of AgRP-DsiRNA using a 48 h food deprivation challenge as this represents a natural
energetic challenge that markedly upregulates AgRP and NPY expression [40, 47, 48].
Importantly, we confirmed the efficacy of AgRP-DsiRNA-mediated gene knockdown with two
complementary techniques (in situ hybridization and qPCR), repeated across multiple
experimental cohorts, and found a comparable ~40-50% knockdown with both approaches.
Although antisense oligo stability in vivo may be increased with the use of transfection agents
[49], the sufficiency of saline diluted oligos demonstrated here and by others [38] circumvents
possible toxicity affecting behavior (for review see [34]). In addition, modified oligo duplexes
(i.e. DsiRNAs) have an elimination half-life of approximately ~0.8 h compared with ~1.5 h for
conjugated duplexes [50]; however, we overcame this temporal limitation by giving a relatively
high dose of AgRP-DsiRNA (0.4µg/g BM) daily to efficiently block AgRP expression. Our
experimental approach employed here has several advantages and broad implications for future
work. Of note, DsiRNA facilitates targeted gene knockdown without surgery, virally mediated
gene delivery, or genome modification, and is in turn clinically relevant for humans. Indeed,
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there are currently at least 20 antisense drugs in development and one currently approved
(Vitravene) for humans [34, 51]. Moreover, this approach can be rapidly adapted to any animal
species and mRNA sequence with minimal side effects, and therefore avoids the inherent
limitations of generating knockout or knockin animal models.
Our findings here that AgRP knockdown attenuates food deprivation- and ghrelininduced increases in food hoarding is complementary to our recent pharmacological data
demonstrating central AgRP drives food hoarding largely independent of food foraging or food
intake [33]. AgRP-DsiRNA attenuated short-term (days 1-3) food hoarding following food
deprivation and exogenous ghrelin, and prolonged (combined days 4-6) food deprivationinduced hoarding. This is of particular importance and clinical relevance as studies suggest food
deprivation increases food hoarding but not food intake in humans [8-11]. Although AgRP
knockdown attenuated food deprivation-induced increases in food hoarding on days 4-6 relative
to baseline, we found no difference between AgRP-DsiRNA and scRNA treatment on days 2-3
post-refeeding. To this end, the profound energy deficit following a food deprivation challenge
markedly upregulates AgRP and NPY expression, and although AgRP-DsiRNA significantly
decreases AgRP mRNA, we speculate that remaining AgRP mRNA due to an incomplete
knockdown is sufficient to drive the acute increase in food hoarding relative to baseline. Our
findings that AgRP-DsiRNA treatment had no effect on basal hoarding levels compared with
controls (i.e. saline + scRNA) prior to exogenous ghrelin or on any subsequent day for the
duration of the experiment would support this and suggests food hoarding increases are
dependent on AgRP upregulation. We cannot, however, rule out the possibility that NPY
signaling is sufficient to regulate food hoarding on days 2-3 post-refeeding or basal food
hoarding in the absence of AgRP. In addition, we did not examine other Arc neuron populations
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that AgRP antagonizes, including neurons expressing the anorectic peptide pro-opiomelanocortin
(POMC) [27, 52]. It is therefore possible an increase in POMC due to inhibition release, or
compensatory decrease due to an absence of AgRP antagonism, is involved in our observed
phenotype. However, as POMC neurons are also inhibited by NPY [53], which was left
unchanged during AgRP knockdown, we speculate that POMC neurons are not involved in
AgRP-DsiRNA-mediated hoarding blockade.
Under the baseline condition where food was abundantly available, we observed the
significantly large “surplus” pellets left on top of the foraging apparatus. This was possibly due
to their constant effort to forage enough pellets in order to prevent any possible food deficiency;
whereas under energetic challenges (eg, food deprivation), they forage less, hoard more, and
waste less to conserve energy, and to achieve the same purpose, to avoid future food deficiency.
Under the latter condition, the marked food deprivation-induced increase in food hoarding was
coupled with significantly decreased food intake and food foraging compared with baseline in
both scRNA and AgRP-DsiRNA treated animals. Although food intake returned to baseline by
day 3 or combined days 4-6 post-refeeding, food foraging remained depressed for the duration of
the experiment in both groups. Of note, this decrease in food foraging and food intake was
coupled with a marked decrease in body mass and % fat mass, and would lend support to our
previous findings that lipectomized hamsters markedly increase food hoarding and decrease
foraging across 12 weeks [54]. We speculate this decrease in food foraging is an evolutionary
adaption to conserve energy in response to the profound energetic challenge of food deprivation
and resulting depletion of energy stores. Food deprivation markedly increases AgRP expression,
which conveys a negative valence signal [55], causing the avoidance of situations associated
with painful experiences (hunger). Animals compensate for decreased energy supply, in part, by
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decreasing energy expenditure (i.e. wheel running) [56], and once food becomes available, food
hoarding is markedly increased as a mechanism to avoid future energetic challenges and negative
valence signals. As the number of pellets earned is decreased, and pellets hoarded increased,
there is a resulting decrease in pellets consumed and surplus pellets. Hence, animals decrease
wheel running/foraging effort (thereby conserving energy), hoard more, and waste less in an
effort to regain body mass and avoid future energetic challenges. Our data would support this
idea as there is a marked decrease in surplus pellets following refeeding (~50 pellets) compared
with baseline (~320 pellets). Moreover, the number of pellets hoarded is several orders of
magnitude greater than baseline at day 1, and this corresponds with the greatest decrease in food
intake and pellet surplus. On days 2-3 and 4-6, food intake begins to return to baseline and there
is a concurrent decrease in food hoarding. As we found a significant difference in foraging effort
between AgRP-DsiRNA and scRNA treated animals, we speculate that AgRP knockdown
attenuates the negative valence signals conveyed by AgRP neurons and this translates, at least
initially, to a relative increase in food foraging and decrease in food hoarding. The marked
decrease in body mass and food foraging through day 6 post-refeeding strongly suggests the
profound energy deficit following fasting is compensated for through increased food hoarding
and decreased food foraging.
Although we found here a marked increase in food hoarding following exogenous ghrelin
at combined days 1-3, this was coupled with a notable absence, and in fact significant decrease,
in food foraging and food intake in contrast to our previous findings [22, 23]. We posit that
these seemingly contrasting results are primarily due to differences in experimental design. We
have previously used a within subject design when measuring the effects of ghrelin on ingestive
behaviors at hourly time points, and converted data to % control (i.e. relative to vehicle) rather
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than a between subject design in this study in which data are expressed as raw values or %
baseline. In turn, stress associated with the novelty of the injection procedure is abrogated with a
within subject, but readily apparent in a between subject design or when compared with %
baseline (in which animals are not manipulated). Moreover, and perhaps most significantly,
ghrelin-induced increases in food foraging and food intake are comparatively small relative to
hoarding and are gone by ~4 h post- injection [22, 23]. In turn, the experimental design here in
which we examine daily changes in ingestive behaviors following energetic challenges does not
allow for the temporal resolution necessary to identify changes in food foraging or food intake
following exogenous ghrelin treatment. We therefore speculate significant increases in hoarding
are apparent with daily measurements, but increases in food foraging and food intake necessitate
greater temporal resolution (e.g. hourly measurements). As such, we are as of now unable to
definitely state that AgRP knockdown has no effect on acute food foraging or food intake
following energetic challenges.
3.6

Conclusions
In summary, our results collectively indicate a critical role of AgRP signaling in

regulating food hoarding following energetic challenges. To this end, AgRP neurons project, in
discrete populations, to a distributed network of forebrain and hindbrain nuclei [57]; however,
future work investigating AgRP efferent nuclei is necessary to fully elucidate the exact
mechanism of AgRP-mediated food hoarding. Coupled with our previous findings that central
AgRP selectively drives food hoarding, our finding here showing that AgRP knockdown
attenuates ghrelin- and food deprivation-induced increases in food hoarding strongly suggests
downstream AgRP signaling underlies this important behavior. Moreover, as NPY drives acute
increases in ingestive behaviors [31], we hypothesize that energetic challenges increase
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appetitive and consummatory feeding behaviors through temporally distinct mechanisms. AgRP
neurons function, at least in part, to negate energy deficits (i.e. following food deprivation)
through short-term, NPY-mediated food intake and prevent future challenges through AgRPmediated food hoarding.
3.7

Acknowledgements
This research was supported by NIH R01DK035254 to T.J.B. and B.X., NIH

R01DK107544 to B.X., and a Georgia State University pre-doctoral dissertation grant to M.A.T.
3.8

Disclosures
The authors have nothing to disclose, financial or otherwise.

3.9

References

[1] Calle, E. E., Rodriguez, C., Walker-Thurmond, K., Thun, M. J. Overweight, obesity, and
mortality from cancer in a prospectively studied cohort of U.S. adults. N.Engl.J Med.
2003,348:1625-38.
[2] Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., et
al. Guidelines for the primary prevention of stroke: a guideline for healthcare
professionals from the American Heart Association/American Stroke Association. Stroke.
2011,42:517-84.
[3] Harvey, A. E., Lashinger, L. M., Hursting, S. D. The growing challenge of obesity and
cancer: an inflammatory issue. Ann.N.Y.Acad.Sci. 2011,1229:45-52.
[4] Vague, J., Vague, P., Tramoni, M., Vialettes, B., Mercier, P. Obesity and diabetes. Acta
Diabetol.Lat. 1980,17:87-99.
[5] Zalesin, K. C., Franklin, B. A., Miller, W. M., Peterson, E. D., McCullough, P. A. Impact of
obesity on cardiovascular disease. Med.Clin.North Am. 2011,95:919-37.
[6] Bartness, T. J., Keen-Rhinehart, E., Dailey, M. J., Teubner, B. J. Neural and hormonal
control of food hoarding. Am.J Physiol. 2011,301:R641-R55.
[7] Craig, W. Appetites and aversions as constituents of instincts. Biol.Bull. 1918,34:91-107.
[8] Beneke, W. M., Davis, C. H. Relationship of hunger, use of a shopping list and obesity to
food purchases. Int.J.Obes. 1985,9:391-9.

88

[9] Dodd, D. K., Stalling, R. B., Bedell, J. Grocery purchases as a function of obesity and
assumed food deprivation. Int.J Obes. 1977,1:43-7.
[10] Mela, D. J., Aaron, J. I., Gatenby, S. J. Relationships of consumer characteristics and food
deprivation to food purchasing behavior. Physiol Behav. 1996,60:1331-5.
[11] Ransley, J. K., Donnelly, J. K., Botham, H., Khara, T. N., Greenwood, D. C., Cade, J. E.
Use of supermarket receipts to estimate energy and fat content of food purchased by lean
and overweight families. Appetite. 2003,41:141-8.
[12] Bartness, T. J., Clein, M. R. Effects of food deprivation and restriction, and metabolic
blockers on food hoarding in Siberian hamsters. Am.J.Physiol. 1994,266:R1111-R7.
[13] Wood, A. D., Bartness, T. J. Food deprivation-induced increases in hoarding by Siberian
hamsters are not photoperiod-dependent. Physiol Behav. 1996,60:1137-45.
[14] Bartness, T. J. Food hoarding is increased by pregnancy, lactation and food deprivation in
Siberian hamsters. Am.J.Physiol. 1997,272:R118-R25.
[15] Day, D. E., Bartness, T. J. Effects of foraging effort on body fat and food hoarding by
Siberian hamsters. J.Exp.Zool. 2001,289:162-71.
[16] Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M. S., Suganuma, T., et al.
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct
endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology.
2000,141:4255-61.
[17] Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., et al. Stomach is
a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like
immunoreactivity levels in humans. J.Clin.Endocrinol.Metab. 2001,86:4753-8.
[18] Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., Weigle, D. S. A
preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.
Diabetes. 2001,50:1714-9.
[19] Tschop, M., Smiley, D. L., Heiman, M. L. Ghrelin induces adiposity in rodents. Nature.
2000,407:908-13.
[20] Wren, A. M., Small, C. J., Ward, H. L., Murphy, K. G., Dakin, C. L., Taheri, S., et al. The
novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.
Endocrinology. 2000,141:4325-8.
[21] Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., et al.
Ghrelin enhances appetite and increases food intake in humans. J.Clin.Endocrinol.Metab.
2001,86:5992.
[22] Keen-Rhinehart, E., Bartness, T. J. Peripheral ghrelin injections stimulate food intake,
foraging and food hoarding in Siberian hamsters. Am.J.Physiol. 2005,288:R716-R22.

89

[23] Thomas, M. A., Ryu, V., Bartness, T. J. Central ghrelin increases food foraging/hoarding
that is blocked by GHSR antagonism and attenuates hypothalamic paraventricular
nucleus neuronal activation. Am J Physiol Regul Integr Comp Physiol. 2015:ajpregu
00216 2015.
[24] Faulconbridge, L. F., Cummings, D. E., Kaplan, J. M., Grill, H. J. Hyperphagic effects of
brainstem ghrelin administration. Diabetes. 2003,52:2260-5.
[25] Zigman, J. M., Jones, J. E., Lee, C. E., Saper, C. B., Elmquist, J. K. Expression of ghrelin
receptor mRNA in the rat and the mouse brain. J.Comp Neurol. 2006,494:528-48.
[26] Wang, Q., Liu, C., Uchida, A., Chuang, J. C., Walker, A., Liu, T., et al. Arcuate AgRP
neurons mediate orexigenic and glucoregulatory actions of ghrelin. Mol.Metab.
2014,3:64-72.
[27] Cone, R. D., Cowley, M. A., Butler, A. A., Fan, W., Marks, D. L., Low, M. J. The arcuate
nucleus as a conduit for diverse signals relevant to energy homeostasis. Int.J Obes.Relat
Metab Disord. 2001,25 Suppl 5:S63-S7.
[28] Chen, H. Y., Trumbauer, M. E., Chen, A. S., Weingarth, D. T., Adams, J. R., Frazier, E. G.,
et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agoutirelated protein. Endocrinology. 2004,145:2607-12.
[29] Gropp, E., Shanabrough, M., Borok, E., Xu, A. W., Janoschek, R., Buch, T., et al. Agoutirelated peptide-expressing neurons are mandatory for feeding. Nat.Neurosci.
2005,8:1289-91.
[30] Krashes, M. J., Shah, B. P., Koda, S., Lowell, B. B. Rapid versus delayed stimulation of
feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP.
Cell Metab. 2013,18:588-95.
[31] Day, D. E., Keen-Rhinehart, E., Bartness, T. J. Role of NPY and its receptor subtypes in
foraging, food hoarding, and food intake by Siberian hamsters. Am.J Physiol
Regul.Integr.Comp Physiol. 2005,289:R29-R36.
[32] Keen-Rhinehart, E., Bartness, T. J. NPY Y1 receptor is involved in ghrelin- and fastinginduced increases in foraging, food hoarding, and food intake. Am.J Physiol
Regul.Integr.Comp Physiol. 2007,292:R1728-R37.
[33] Day, D. E., Bartness, T. J. Agouti-related protein increases food hoarding, but not food
intake by Siberian hamsters. Am.J.Physiol. 2004,286:R38-R45.
[34] Behlke, M. A. Progress towards in vivo use of siRNAs. Mol Ther. 2006,13:644-70.
[35] Bowers, R. R., Festuccia, W. T. L., Song, C. K., Shi, H., Migliorini, R. H., Bartness, T. J.
Sympathetic innervation of white adipose tissue and its regulation of fat cell number.
Am.J.Physiol. 2004,286:R1167-R75.

90

[36] Hamar, P., Song, E., Kokeny, G., Chen, A., Ouyang, N., Lieberman, J. Small interfering
RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl
Acad Sci U S A. 2004,101:14883-8.
[37] Suda, T., Liu, D. Hydrodynamic gene delivery: its principles and applications. Mol Ther.
2007,15:2063-9.
[38] Ocker, M., Neureiter, D., Lueders, M., Zopf, S., Ganslmayer, M., Hahn, E. G., et al.
Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.
Gut. 2005,54:1298-308.
[39] Mercer, J. G., Moar, K. M., Ross, A. W., Morgan, P. J. Regulation of leptin receptor,
POMC and AGRP gene expression by photoperiod and food deprivation in the
hypothalamic arcuate nucleus of the male Siberian hamster (Phodopus sungorus).
Appetite. 2000,34:109-11.
[40] Garretson, J. T., Teubner, B. J., Grove, K. L., Vazdarjanova, A., Ryu, V., Bartness, T. J.
Peroxisome proliferator-activated receptor gamma controls ingestive behavior, agoutirelated protein, and neuropeptide Y mRNA in the arcuate hypothalamus. J Neurosci.
2015,35:4571-81.
[41] Vazdarjanova, A., McNaughton, B. L., Barnes, C. A., Worley, P. F., Guzowski, J. F.
Experience-dependent coincident expression of the effector immediate-early genes arc
and Homer 1a in hippocampal and neocortical neuronal networks. J.Neurosci.
2002,22:10067-71.
[42] Garretson, J. T., Teubner, B. J., Ryu, V., Bartness, T. J. Role of Peroxisome Proliferatoractivated Receptor ã in Appetite Control. The Obesity Society. 2013.
[43] Paxinos, G., Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. New
York: Academic Press; 2007.
[44] van der Laan, S., Lachize, S. B., Schouten, T. G., Vreugdenhil, E., de Kloet, E. R., Meijer,
O. C. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (NCoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain. Brain
Res. 2005,1059:113-21.
[45] Mercer, J. G., Moar, K. M., Ross, A. W., Hoggard, N., Morgan, P. J. Photoperiod regulates
arcuate nucleus POMC, AGRP, and leptin receptor mRNA in Siberian hamster
hypothalamus. Am.J.Physiol. 2000,278:R271-R81.
[46] Perrigo, G., Bronson, F. H. Foraging effort, food intake, fat deposition, and puberty in
female mice. Biology of Reproduction. 1983,29:455-63.
[47] Harrold, J. A., Williams, G., Widdowson, P. S. Changes in hypothalamic agouti-related
protein (AGRP), but not alpha- MSH or pro-opiomelanocortin concentrations in dietaryobese and food- restricted rats. Biochemical and Biophysical Research Communications.
1999,258:574-7.

91

[48] Bi, S., Robinson, B. M., Moran, T. H. Acute food deprivation and chronic food restriction
differentially affect hypothalamic NPY mRNA expression. Am.J.Physiol
Regul.Integr.Comp Physiol. 2003,285:R1030-R6.
[49] Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., et al.
Therapeutic silencing of an endogenous gene by systemic administration of modified
siRNAs. Nature. 2004,432:173-8.
[50] Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., et al.
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat
Biotechnol. 2005,23:1002-7.
[51] Crooke, S. T. Progress in antisense technology. Annual review of medicine. 2004,55:61-95.
[52] Dhillo, W. S., Small, C. J., Stanley, S. A., Jethwa, P. H., Seal, L. J., Murphy, K. G., et al.
Hypothalamic interactions between neuropeptide y, agouti-related protein, cocaine- and
amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in
male rats. J.Neuroendocrinol. 2002,14:725-30.
[53] Garcia de, Y. E., Li, S., Fournier, A., St-Pierre, S., Pelletier, G. Regulation of
proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain
Res. 1995,674:112-6.
[54] Dailey, M. E., Bartness, T. J. Fat pad-specific effects of lipectomy on foraging, food
hoarding, and food intake. Am.J.Physiol Regul.Integr.Comp Physiol. 2008,294:R321-R8.
[55] Betley, J. N., Xu, S., Cao, Z. F., Gong, R., Magnus, C. J., Yu, Y., et al. Neurons for hunger
and thirst transmit a negative-valence teaching signal. Nature. 2015,521:180-5.
[56] Luz, J., Griggio, M. A., Natrieli, R. M., Aumond, M. D. Energy balance of rats subjected to
continuous and intermittent food restriction. Braz.J Med.Biol.Res. 1995,28:1019-23.
[57] Betley, J. N., Cao, Z. F., Ritola, K. D., Sternson, S. M. Parallel, redundant circuit
organization for homeostatic control of feeding behavior. Cell. 2013,155:1337-50.

92

4

GHRELIN ACTIVATES PERIPHERAL SENSORY NEURONS TO REGULATE
METABOLIC HOMEOSTASIS INDEPENDENT OF FOOD INTAKE

4.1

Abstract
Obesity is a major health and economic burden with approximately 35% of United States

citizens classified as either overweight or obese, and medical spending for treating obesity and
its comorbidities exceeds $200 billion annually. The stomach-derived orexigenic hormone
ghrelin is a key mediator of energy homeostasis and adiposity in humans due to its regulation of
food intake, gut motility, energy expenditure, nutrient partitioning, glycemia, and body
temperature. The ghrelin receptor, growth hormone secretagogue receptor 1a (GHSR), is widely
expressed in the brain and on gastrointestinal vagal sensory neurons, and neuronal GHSR
knockout results in a profoundly beneficial metabolic profile and diet-induced obesity (DIO)
resistance. Moreover, ghsr knockout mice have impaired metabolic regulation during energetic
challenges, and ghsr restoration in the brain does not fully restore ghrelin’s effects suggesting
peripheral ghrelin signaling is critical for metabolic control. In the current study, we demonstrate
that in addition to the well characterized vagal GHSRs, gastrointestinal sensory neurons
emanating from spinal dorsal root ganglia (DRG) robustly express GHSRs that are activated by
energetic challenges indicating a novel mechanism mediating ghrelin’s effects on energy
homeostasis. Sensory neuron GHSR deletion attenuates DIO through increased energy
expenditure and sympathetic outflow to BAT and WAT, and this upregulated sympathetic
outflow results in a marked increase in cold tolerance and adipose tissue browning capacity.
Hence, these findings demonstrate a novel ghrelin signaling pathway critical for maintaining
energy homeostasis and provides another point of attack for behavioral and/or pharmacological
interventions to combat obesity.
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4.2

Introduction
The number of overweight and obese persons worldwide has continually risen across the

last four decades with the current number of affected persons estimated 1.9 billion [1].
Prolonged energy intake that exceeds energy expenditure can result in obesity and markedly
increase the risk for secondary health consequences including type 2 diabetes, cardiovascular
disease, and cancer [2-4]. As such, there has been considerable effort placed on uncovering the
mechanisms regulating energy homeostasis. Neuroendocrine systems that mediate this
homeostasis are broadly distributed in the brain and periphery and form a complex,
interconnected framework governing energy intake and expenditure, adipose tissue metabolism,
and ingestive behaviors [5-7]. Both central and peripheral endocrine signaling is sufficient to
regulate metabolism (for review see [5]), yet the mechanisms through which these pathways
function independently or in parallel is largely unstudied. To this end, gastric sensory neurons
that detect nutrients or distension express endocrine receptors [8], and these afferents are
sufficient to regulate adipose tissue metabolism [9]. Moreover, these sensory neurons can form
short or long feedback loops within the spinal cord and hindbrain respectively [9-11], and this
central-peripheral crosstalk is critical for maintaining metabolic homeostasis. As the number of
obese persons worldwide continues to increase, a comprehensive study investigating the
peripheral mechanisms controlling ingestive behaviors and energy homeostasis may provide
more accessible pharmacological interventions as these receptors are independent of the brain
and blood brain barrier.
Ghrelin is a 28-amino acid peptide hormone secreted from the stomach [12]. Circulating
ghrelin levels rise pre-prandially (i.e. during fasting) and decrease post-prandially, and the rise
and fall of ghrelin concentrations is suggested as contributor to normal energy homeostasis and
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overall metabolic health [13, 14]. In both humans and rodents, activation of the ghrelin receptor,
growth hormone secretagogue receptor 1a (GHSR) [15], markedly increases adiposity through
increased food intake [16, 17], decreased energy expenditure, and reduced fatty acid utilization
[18, 19]. Moreover, exogenous ghrelin decreases core body temperature [20], attenuates brown
adipose tissue (BAT) thermogenesis [20], and reduces insulin secretion resulting in
hyperglycemia [21, 22]. GHSRs are widely expressed in the brain and on peripheral neurons
including gastric vagal afferents [23, 24], and GHSR deletion or blockade prevents diet-induced
obesity (DIO), ghrelin-induced ingestive behaviors [17, 25, 26], and significantly increases
energy expenditure [27], thermogenic capacity [27], and insulin sensitivity [28]. However, ghsr
restoration in the brain does not fully restore ghrelin’s effects suggesting peripheral ghrelin
signaling is critical for metabolic control [29]. Integration of peripheral sensory information in
the brain is mandatory for maintaining energy homeostasis [30-32], and dysregulated sensory
neuron function and ghrelin signaling is well documented in the obese [33-35]. In lean humans
and rodents, activation of gastric stretch or nutrient receptors promotes satiety [36-38], and their
activity is directly enhanced by anorectic gut hormones and inhibited by ghrelin [5, 39]. In
addition, activation of intestinal nutrient receptors increases BAT thermogenesis [9], a key
mediator of whole body energy expenditure and adiposity [40], indicating an important link
between gastrointestinal stimuli, sensory neuron activation, ghrelin signaling, and metabolic
control. Initial studies suggested ghrelin-mediated energy expenditure regulation, thermogenesis,
gut motility, and glycemic control is dependent on intact gastric vagal afferents [41-43].
However, non-vagal sensory neurons innervate the gut at all levels [44], and vagotomized
animals have normal adaptation to cold challenges and gastric responses to an exogenous ghrelin
challenge suggesting non-vagal GHSR-containing sensory neurons are sufficient to mediate
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these responses [45-48]. Total sensory neuron ablation following capsaicin treatment impairs
adipose tissue metabolism, cold-induced thermogenic responses, and, at the very least, ghrelin’s
gastric effects indicating DRG sensory neurons are mandatory for metabolic control [49-51].
To interrogate the role of peripheral ghrelin signaling in regulating metabolic
homeostasis, we used a GHSR-IRES-tauGFP mouse [52] and found robust GHSR expression on
DRG sensory neurons that are activated by energetic challenges including food deprivation and
cold exposure. We next characterized the necessity of this peripheral ghrelin signaling pathway
in regulating metabolic homeostasis by generating a novel, sensory neuron specific GHSR
knockout mouse, and found these mice had a marked increase in energy expenditure and adipose
thermogenic gene expression that resulted in diet-induced obesity resistance and improved cold
tolerance despite no changes in food intake. This peripheral ghrelin signaling pathway functions
in parallel to previously defined central feeding circuits and indicates a novel mechanism
through which sensory neuron ghrelin signaling regulates adipose tissue metabolism and wholebody energy homeostasis. Hence, this discrete sensory neuron pathway may provide a novel
therapeutic avenue to prevent or reverse obesity.
4.3

Materials and Methods

4.3.1 Animals
Adult Ghsr-IRES-tauGFP mice were obtained from the Jackson Laboratory (Stock No:
019908). To generate a sensory neuron specific Ghsr knockout model, we crossed our existing
Advillin-Cre mouse line [53, 54] with Ghsrf/f mice [27] (mouse lines were kindly provided by
Drs. Fan Wang from Duke University and Yuxiang Sun at Texas A&M University respectively)
to generate Advillin-Cre+/-;Ghsrf/f mice (henceforth referred to as AGKO). Male AGKO or f/f
littermate mice were fed either a standard chow diet (catalog no.: 5001; LabDiet; Purina, St.
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Louis, MO) or high fat diet (HFD) consisting of 60% calories from fat (catalog no. 12492;
Research Diets, New Brunswick, NJ). Body mass measurements were taken weekly for the
duration of the experiment. Animals were maintained at ~23°C with 12-hour light/dark cycles
(0700-1900 light). All procedures were approved by the Georgia State University Institutional
Animal Care and Use Committee and were in compliance with the Public Health Service and
United States Department of Agriculture guidelines.
4.3.2 Physiology Measurements
Glucose and insulin tolerance tests were performed on male AGKO or f/f littermate mice
after 12 weeks on either Chow or high-fat diet (HFD) as we observed the greatest difference in
body mass during this time. For glucose tolerance tests, animals were fasted for 16 hours
overnight. Baseline glucose measurements were obtained from a tail nick using a OneTouch
Ultra Blood Glucose Meter and glucose test strips (LifeScan, Inc., Milpitas, CA). Following the
initial measurement, mice were intraperitoneally injected with a 20% dextrose solution (1g/kg
body mass), and subsequent blood glucose measurements were performed at 15, 30, 60, 90, and
120 minutes after the glucose injection. For the insulin tolerance test (ITT), mice were fasted for
4 hours prior to the start of the procedure, and baseline blood glucose was measured from a small
tail nick. Mice were then intraperitoneally injected with 1.0 U/kg insulin (Humulin R; Eli Lilly,
Indianapolis, IN), and blood glucose was measured at the same time points used for the GTT.
Energy expenditure, oxygen consumption, carbon dioxide production, respiratory exchange ratio,
and physical activity data were collected for male AGKO or f/f littermate mice using a TSE
PhenoMaster metabolic chamber system (TSE Systems, Chesterfield, MO) after 12 weeks on
Chow or HFD. Animals were allowed a 48-hour acclimation period prior to the start of data
collection and then returned to their home cage at the end of the experiment.
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4.3.3 Body Composition Measurements
Body composition measurements were taken for HFD-fed male AGKO or f/f littermate
mice using our Minispec LF90 TD-NMR analyzer (Bruker Optics). For all measurements,
animals were briefly removed from their home cage, placed in the body composition analyzer,
and then immediately returned to their home cage. Body composition measurements were taken
for all animals prior to the start of HFD feeding, after 8 weeks of HFD feeding, and then again at
the conclusion of the experiment.

4.3.4 Tissue Collection
At the end of each experiment, mice were euthanized using carbon dioxide inhalation.
Blood serum was collected and stored at −80°C until analysis. Animals were then perfused with
ice cold 0.1M PBS and fat pads (brown (iBAT), epididymal (eWAT), and inguinal (iWAT)),
liver, brain, and DRGs (L5-T5 levels) dissected and flash frozen in liquid nitrogen. For brain
microdissection, the brain was placed on an ice cold cutting block and 1 mm sagittal sections
taken from both sides of the midline. The arcuate hypothalamus, paraventricular hypothalamus,
ventromedial hypothalamus, and ventral tegmental area were then microdissected according to a
mouse brain atlas (Paxinos and Franklin [55]) and flash frozen in liquid nitrogen. A sample of
each fat pad and liver was taken prior to freezing and placed in formalin for later histological
analysis. In a separate set of Ghsr-GFP mice used for immunohistochemical analysis, animals
were euthanized by carbon dioxide inhalation and then transcardially perfused with 75 ml 0.9%
heparinized saline followed by 150 ml 4.0% paraformaldehyde in 0.1 M PBS in sterile filtered
dH2O. DRGs (L5-T5 levels) were subsequently removed and dehydrated in an 18% sucrose
solution until immunohistochemical analysis.
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4.3.5 Fast Blue Injections
1% Fast Blue in sterile dH2O (17740-1, Polysciences, Warrington, PA) was used as a
fluorescent retrograde neuronal tracer to identify gastrointestinal-projecting sensory neurons. In
brief, animals were deeply anesthetized with 1-2% isoflurane, and a small incision was made on
the ventral midline to expose the peritoneal cavity and discrete gut regions (i.e. stomach and
small and large intestine). A series of 0.5-1 µl injections were given across 4 loci along greater
curvature of the stomach or across 8 evenly spaced loci along the small or large intestine through
a 26-gauge needle and syringe. The peritoneal cavity was then closed with sterile dissolvable
sutures and the skin incision closed with sterile wound clips. Animals were given 7 days to
recover and allow for retrograde Fast Blue transport before euthanization and tissue extraction as
described above.

4.3.6 Histological Analysis
For DRG GFP immunohistochemical quantification in our Ghsr-GFP mice injected with
Fast Blue (see above), DRGs (L5-T5 levels) were removed from the sucrose solution and sliced
in a cryostat at 25 µm. DRG sections were taken in series across three slides (SuperFrost Plus
slides (Thermo Fisher Scientific); 8 sections/slide total) to prevent a single neuron being present
multiple times on the same slide as previously described [30, 53]. For immunohistochemical
staining, in brief, slides were washed 3X15 min in sterile 0.1M PBS on a rotator. DRG sections
were blocked with 5% normal horse serum containing 0.3% Triton X-100 in 0.1M PBS for 1 h.
Slides were then incubated overnight at room temperature with rabbit anti-cFOS (1:500; sc-52,
Santa Cruz Biotechnology, Santa Cruz, CA) and chicken anti-GFP (1:400; GFP2020, AvesLabs,
Tigard, OR) antibodies in 0.1M PBS with 0.3% Triton X-100 and 10% normal horse serum.
Next, slides were washed 3X 15 min in 0.1M PBS and then incubated at 4°C for 24 h with
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donkey anti-chicken-488 (1:1000; 703-545-155, Jackson Immunoresearch, West Grove, PA) and
donkey anti-rabbit-CY3 (1:400; 711-165-152, Jackson Immunoresearch, West Grove, PA) in
0.1M PBS. Slides were then washed 3 X 15 min with 0.1M PBS and coverslipped with Prolong
antifade fluorescent medium (Invitrogen). Images were captured using an Olympus DP73
photomicroscope and CellSens software (Olympus, Waltham, MA). For GFP, cFOS, and Fast
Blue quantification, total cell numbers were estimated by counting the number of fluorescently
positive neurons on a single section and then multiplying this number by 8 as each slide contains
8 sections as previously described [32].

For adipose tissue immunohistochemical analysis, samples were removed from formalin,
dehydrated through a series of increasing isopropanol washes, and embedded in paraffin blocks.
iBAT, iWAT, and eWAT were sliced at 5 µm on a rotating microtome and mounted on
SuperFrost Plus slides (Thermo Fisher Scientific). Slides were deparaffinized and hydrated by
washing in p-xylenes followed by a series of decreasing ethanol washes. Sections were next
incubated in DAKO antigen retrieval solution (DAKO, S1699) and heated in a microwave for 14
minutes total. Rabbit anti-UCP1 antibody (ab10983, Abcam) 1:150 was applied to all sections
and then incubated overnight at 4°C. Slides were then washed 4 X 30s in a tris buffer solution
and the secondary biotinylated mouse adsorbed donkey anti-rabbit antibody (Jackson
ImmunoResearch, 711-065-152) applied to all sections and incubated for 30 min. at room
temperature. Slides were washed 4 X 30s in tris buffer and then incubated in an ABC solution
(Vector Labs, PK-6100) for 30 min. at room temperature. Sections were then washed 2 X 30s in
1M tris-HCl solution and then incubated in a DAB reaction solution (Vector Labs, SK-4100) for
5-15 min. Slides were washed in dH2O for 5 min. and then dehydrated through graded alcohol
washes followed by a final p-xylene wash. Slides were then coverslipped with permount (Fisher,
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SP15-100), allowed to dry, and imaged with an Olympus DP73 photomicroscope and CellSens
software (Olympus, Waltham, MA).

For hematoxylin and eosin adipose tissue histology, samples were removed from
formalin, dehydrated through a series of increasing isopropanol washes, and embedded in
paraffin blocks. iBAT, iWAT, and eWAT were sliced at 5 µm on a rotating microtome and
mounted on SuperFrost Plus slides (Thermo Fisher Scientific). Tissue morphology was visually
analyzed using hematoxylin and eosin staining (Sigma-Aldrich). Adipose histology images were
captured using an Olympus DP73 photomicroscope and CellSens software (Olympus, Waltham,
MA).
4.3.7 In Vitro DRG Culture
Adult Ghsr-GFP mice were euthanized by carbon dioxide inhalation, and DRGs (L5-T5
levels) immediately removed and placed in ice cold 0.1M PBS with 20mM HEPES. This
solution was then replaced with 1mg/ml collagenase 1 (Worthington Biochemical Corporation
CLS-1) in 0.1M PBS and 20mM HEPES for 60-90 min at 37°C followed by 0.05% TrypsinEDTA (Sigma T9201) solution in 0.1M PBS and 20mM HEPES for 7 min at 37°C. DRGs were
then washed 2X with 1ml complete neurobasal media (Fisher 10888022) with 1X B-27 (Fisher
17504044) and 200µM L-glutamine (Fisher 25030149). Next, 600µl complete neurobasal media
was added and the DRGs triturated 30X. Dissociated neurons were filtered through a 100µm
cell strainer into a new microcentrifuge tube and then washed 2X with 500µl complete
neurobasal media. Neurons were then centrifuged for 5 min at 200g, the supernatant removed
and replaced with 1ml complete neurobasal media, triturated 3X, and then seeded onto Poly-DLysine and Laminin coated coverslips. Cultured neurons were transferred to a 37°C + 0.5% CO2
incubator until use.

101

4.3.8 Calcium Imaging and Electrophysiology
For calcium imaging, coverslips containing cultured DRG neurons were transferred to a
new 3.5mm dish containing 5µM Fura-2 AM (MilliporeSigma 344905) in complete neurobasal
media and placed in a 37°C + 0.5% CO2 incubator for 30 min. Neurons were then washed 3X
with an extracellular recording solution composed of 152mM NaCl, 2.8mM KCl, 10mM HEPES,
2mM CaCl2, and 10mM glucose and placed in a 37°C for 20-30 min to allow for intracellular
deesterification. Neuronal recording was performed using a Polychrome V monochromator
(TILL Photonics). In brief, GFP-positive neurons were identified under a microscope and
baseline calcium currents were measured for 5-10 min. Next, either 100nM ghrelin (Bachem
4033076) or vehicle (extracellular recording solution) was administered and changes in calcium
currents measured for 30-60 min. At the end of each recording, 60mM KCL was given as a
positive control for neuronal viability, and only neurons that were depolarized by KCl were used
for analysis.

For electrophysiological recordings, DRG neurons were extracted from Ghsr-GFP mice
and dissociated as described above. Dissociated neurons were plated into 35 mm plastic dishes
coated with poly-D-lysine and used for recording 3-5 days after plating. GFP-labeled DRG
neurons were visualized using a GFP-filtered excitation and emission fluorescent light under an
inverted microscope. Patch-clamp recordings were performed using a Multiclamp 700B
amplifier, Digidata 1440A interphase, and pClamp 10 software (Molecular Devices, Union City,
CA) under voltage-clamp and current clamp modes. The external solution (pH 7.3) consisted of
152 mM NaCl, 2.8 mM KCL, 10 mM HEPES, 2 mM CaCl2, and 10 mM glucose. The
intracellular solution (pH 7.3) consisted of 130 mM K-gluconate, 10 mM HELES, 0.6 mM
EGTA, 0.3 mM K-ATP, 0.3 mM Na-GTP, and 10 mM phosphocreatine.
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4.3.9 Quantitative Gene and Protein Analysis
RNA from frozen tissues was extracted using TRIzol Reagent (Thermo Fisher) according
to the manufacturer’s instructions. Gene expression was measured using a 7500-Fast RT-PCR
machine (Applied Biosystems), ABI Universal PCR Master Mix (Applied Biosystems, Foster
City, CA), and primer and probe sets purchased from Applied BioSystems. Relative gene
expression was determined using the ΔΔCt method with cyclophilin as an internal control [56].
The following genes were assayed:

Acyl-CoA Oxidase 1 (Acox1); β3 Adrenergic Receptor (β3AR); Carnitine
Palmitoyltransferase 1B (Cpt1b); Cell Death-Inducing DFFA-Like Effector A (Cidea);
Cyclooxygenase 1 (Cox1); ELOVL Fatty Acid Elongase 3 (Elovl3); Growth Hormone
Secretagogue Receptor 1a (Ghsr); Iodothyronine Deiodinase 2 (Dio2); Peroxisome Proliferator
Activated Receptor Alpha (Ppar-α); Peroxisome Proliferator Activated Receptor Gamma (Pparγ); PPARG Coactivator 1 Beta (Pgc-1β); PR domain containing 16 (Prdm16); Uncoupling
Protein 1 (Ucp-1); Uncoupling Protein 3 (Ucp-3).

For Western blot analysis, proteins were extracted using a radioimmunoprecipitation
assay buffer with protease inhibitor cocktails (Sigma-Aldrich, St. Louis, MO) and a handheld
homogenizer. Protein concentration was quantified with a DC Protein Assay (BioRad, Hercules,
CA), and protein samples were denatured at 37°C for 30 minutes. 20 to 30 µg protein was
loaded onto a 4% to 15% gradient polyacrylamide gel (Criterion TGX; BioRad, Hercules, CA)
and then transferred to a polyvinylidene difluoride membrane. We immunoblotted the
membranes by blocking with 5% nonfat milk and followed by antibodies against uncoupling
protein 1 (1:500) (catalog no. 23841; Abcam, Cambridge, MA), tyrosine hydroxylase (1:1000)
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(catalog no. AB152; Millipore Sigma, Burlington, MA), pHSL (1:1000) (catalog no. 4126; Cell
Signaling, Danvers, MA), or α-tubulin (1:500) (catalog no. ABCENT4777; Advanced
Biochemicals, Lawrenceville, GA) overnight at 4°C. Next, samples were incubated in an Alexa
Fluor goat anti-rabbit 680 secondary antibody (catalog no. A21109; Thermo Fisher Scientific,
Waltham, MA) at 1:5000 concentration for 3 hours. Bands were visualized and quantified using
an Odyssey Fc Imaging System (Li-Cor, Lincoln, NE) with background subtracted. All
membranes were immunoblotted with and normalized to α-tubulin antibody at 1:500 dilution
(catalog no. 2144S; Cell Signaling).

4.3.10 Cold Exposure
2 weeks prior to the start of cold exposure, 10-week-old AGKO and f/f littermate mice
were implanted with temperature transponders (IPTT-300, BMDS, Seaford, DE). In brief,
animals were deeply anesthetized with 1-2% isoflurane and a small incision made along the
ventral midline to expose the peritoneal cavity. Sterile temperature transponders were inserted
into the peritoneal cavity, the incision closed with sterile dissolvable sutures, and the skin
incision closed with sterile wound clips. Following transponder implantation, animals were
singly housed in shoebox cages with only corn cob bedding for recovery. At the start of the
experiment, baseline body temperature measurements were taken for all animals before being
placed in a 10°C cooler for 7 days. Core body temperature measurements were taken for all
mice every hour for the first 8 hours of the study, and then every 2 hours through 24 h.
Measurements were taken every 2 hours from 0700 to 1900 for the remaining 6 days. At the end
of the experiment, animals were removed from the cooler, immediately euthanized, and tissues
extracted as described above. In a separate set of Ghsr-GFP mice used for
immunohistochemical analysis, mice were placed in the 10°C cooler for 7 days exactly as
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described above, but without implantation of temperature transponders or core body temperature
measurements taken.

4.3.11 Food Intake Studies
For ghrelin-induced food intake measurements, single housed ad libitum Chow-fed or
HFD-fed AGKO and f/f littermate mice were given a 0.5 mg/kg subcutaneous ghrelin challenge
(4033076, Bachem, Torrance, CA) at 0800. Food intake was measured at 30, 60, 90, and 120
min post-injection. For food deprivation-induced food intake, single housed Chow-fed or HFDfed AGKO and f/f littermate mice were food deprived for 16 hours. At 0800, food was returned,
and food intake measured at 30, 60, 90, and 120 min post-refeeding.

4.3.12 Statistical Analysis
All data were expressed as mean ± S.E. Relative expression for all genes measured by
quantitative PCR were normalized to cyclophilin. For calcium imaging experiments, ΔF/F% was
calculated by first taking the average baseline fluorescence across the initial 5-10 min. of the
study. Next, % change in fluorescence was calculated at each timepoint using the formula
[[(TimepointX-baseline)/baseline] * 100]. Experimental data were analyzed by a Student’s ttest, paired t-test, or a two-way or three-way Repeated Measures ANOVA followed by Duncan’s
Multiple-Comparison post-hoc analysis where appropriate. For all experiments, differences
among groups was considered statistically significant at P<0.05 and trending toward significance
at P≤0.1.
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4.4

Results

4.4.1 GHSRs are expressed in vagal and DRG neurons that project to the gastrointestinal
system
We first sought to identify organs innervated by GHSR-containing sensory neurons using
the neuronal tracer Fast Blue. Because ghrelin is predominantly produced in the stomach, we
hypothesized that gastrointestinal sensory neurons would express GHSRs. Indeed, we found that
stomach, small intestine, and large intestine sensory neurons largely originate in the vagus nerve,
but significant DRG innervation exists between T12 and T5 ganglia for all areas [Fig. 4.1 A].
GFP immunohistochemistry revealed strong, consistent labeling in the nodose ganglia and across
all DRG levels in our Ghsr-IRES-tauGFP mice (data not shown), but because Fast Blue most
strongly labeled T12-T5 ganglia we chose to focus our efforts on these levels [Fig. 4.1 B].
Extensive GFP and Fast Blue double labeled neurons were present in these ganglia [Fig. 4.1 CE]. We found significant GFP and Fast Blue colocalization in vagal and DRG neurons that
project to the stomach [Fig. 4.1 F] or small intestine [Fig. 4.1 G] with between 10%-40% GFP
neurons co-labeled with Fast Blue and between 20%-60% Fast Blue neurons co-labeled with
GFP. By contrast, we found significantly less Fast Blue and GFP colocalization in large
intestine projecting sensory neurons and therefore focused our efforts on the stomach and small
intestine (data not shown). Although the presence of GFP indicates GHSR expression in DRGs
and the nodose ganglia, we confirmed these GHSRs were responsive to ghrelin using in vitro
DRG cultures and a combination of electrophysiology and calcium imaging. Using dissociated
DRG neurons from Ghsr-IRES-tauGFP mice, we found that 100 nmol ghrelin increased the
neurons membrane potential and resulted in spontaneous action potentials [Fig. 4.1 H].
Moreover, patch clamp studies found that 100 nmol ghrelin, but not vehicle, significantly
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decreased neuron hyperpolarization [Fig. 4.1 I-J]. We next used in vitro calcium imaging to
confirm our electrophysiology results on Ghsr-IRES-tauGFP mouse DRG neurons. 100 nmol
ghrelin markedly increased calcium efflux from GFP-positive DRG neurons, but this effect was
absent in GFP-negative neurons given 100 nmol ghrelin and in GFP-positive and GFP-negative
neurons receiving vehicle [Fig. 4.1 K-L].

4.4.2 Sensory neuron GHSRs are activated by energetic challenges
After we identified the anatomical distribution of sensory neuron-containing GHSRs and
their response to ghrelin in vitro, we next tested whether these neurons are activated by energetic
challenges. We chose overnight food deprivation and acute (24 h) cold exposure challenges as
these elicit a robust increase in circulating ghrelin [13, 57]. We found that both fasting and cold
exposure significantly increased Arc GHSR expression, but only cold exposure significantly
increased DRG GHSR expression [Fig. 4.2 A, E]. By contrast, neither fasting nor cold exposure
significantly affected the total number of GFP-positive DRG or vagal sensory neurons [Fig. 4.2
B, F]. We next examined whether food deprivation or cold exposure activated DRG and vagal
GHSR-positive neurons in vivo using triple labeling for GFP, Fast Blue, and the neuronal
activity marker cFos [58]. We found that both food deprivation and cold exposure significantly
increased stomach [Fig. 4.2 C, G] and small intestine [Fig. 4.2 D, H] projecting GHSR sensory
neuron activity, and that these energetic challenges robustly induced cFos immunoreactivity
allowing for triple immunofluorescence labeling [Fig. 4.2 I-L].

4.4.3 Sensory neuron GHSR knockout does not affect chow-fed mice
We next examined the endogenous role of sensory neuron GHSR signaling in regulating
energy homeostasis by generating a novel, sensory neuron GHSR knockout mouse model. To
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accomplish this, we crossed our sensory neuron-specific advillin-cre driver mouse line with the
recently generated ghsrf/f mouse [27, 53]. The resultant offspring (henceforth referred to as
AGKO) had normal hypothalamic GHSR expression, but an approximately 90% decrease in
DRG GHSR expression indicating GHSR deletion is specific to peripheral sensory neurons [Fig.
4.3 A]. Chow-fed AGKO mice had no difference in body mass [Fig. 4.3 B, D] nor in
interscapular brown adipose tissue (iBAT), epididymal adipose tissue (eWAT), inguinal adipose
tissue (iWAT), or liver mass compared with f/f littermates [Fig. 4.3 C, E-G]. As GHSRs are
necessary for exogenous ghrelin-induced food intake, we next tested whether AGKO mice
respond to a peripheral ghrelin challenge (0.5 mg/kg body mass) and whether these mice have a
normal feeding response following an overnight fast. In line with previous work indicating
central GHSRs are sufficient to regulate food intake [16, 29], we found that both an exogenous
ghrelin challenge and an overnight fast comparably increased food intake in AGKO and f/f
control mice [Fig. 4.3 H-I]. Moreover, we found no difference in 24 h food intake between
AGKO and f/f littermates [Fig. 4.3 G]. Because ghrelin and ghsr knockout mice have improved
glucose disposal and insulin sensitivity, we next tested glucose and insulin tolerance in our
AGKO mice. We found that chow-fed AGKO and f/f littermate mice had no difference in
glucoregulation following a glucose tolerance test [Fig. 4.3 K], overnight fasting [Fig. 4.3 L],
insulin tolerance test [Fig. 4.3 M], or in ad lib fed plasma insulin concentrations [Fig. 4.3 N].

4.4.4 Chow-fed AGKO mice have increased energy expenditure and adipose thermogenic
gene expression
To characterize the metabolic phenotype of our AGKO mice, we used indirect
calorimetry measurements in our metabolic cage system. We found that AGKO and f/f control
mice had slightly elevated energy expenditure at several time points throughout the experiment
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[Fig. 4.4 A], although we found no significant difference in area under the curve [Fig. 4.4 B].
We found several instances of AGKO mice having higher respiratory quotient measurements
indicating a preferential use of carbohydrates [Fig. 4.4 C], but no difference between AGKO and
f/f mice during either daytime or nighttime as measured by area under the curve [Fig. 4.4 D]. To
identify the mechanism driving this increased energy expenditure, we examined thermogenic
gene expression in adipose tissue as previous studies demonstrated ghsr knockout mice have
significantly increased thermogenic capacity [27]. We found that AGKO mice had markedly
increased thermogenic and β3-adrenergic receptor gene expression in iBAT, eWAT, and iWAT
compared with f/f controls suggesting increased adipose tissue thermogenesis underlies the
elevated energy expenditure in AGKO mice [Fig. 4.4 E-G]. Moreover, AGKO mice had
significantly increased UCP-1 protein content in iBAT, a trend of increased UCP1 in eWAT, and
significantly increased TH proteins in eWAT and iWAT compared with f/f control mice
compared with [Fig. 4.4 H-J].

To confirm our gene and protein expression results, we analyzed AGKO and f/f adipose
tissues using hematoxylin and eosin (H&E) staining and UCP-1 immunohistochemistry (IHC).
Compared with f/f H&E and UCP-1IHC stained iBAT [Fig. 4.5 A, C], AGKO iBAT was
notably darker and had a greater density of UCP-1 staining [Fig. 4.5 B, D]. H&E stained eWAT
was comparable in f/f [Fig. 4.5 E] and AGKO [Fig. 4.5 F], yet AGKO mice had significantly
more UCP-1 staining compared with f/f mice [Fig. 4.5 G, H]. iWAT histological analysis
revealed a marked difference between H&E stained f/f [Fig. 4.5 I] and AGKO [Fig. 4.5 J] mice
such that AGKO iWAT was significantly more BAT-like. Indeed, UCP-1 IHC revealed
markedly more staining in AGKO iWAT compared with f/f iWAT [Fig. 4.5 K, L].
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4.4.5 Diet-induced obesity is attenuated in AGKO mice
The significant increase in energy expenditure and thermogenic capacity led us to
hypothesize that AGKO mice would resist the development of diet induced obesity. We found
that a HFD consisting of 60% calories from fat markedly increased body mass and overall fat
mass in f/f control mice, but this effect was attenuated in AGKO mice [Fig. 4.6 A-B, D]. Tissue
analysis revealed a significant decrease in liver and iWAT mass and a trend for decreased iBAT
mass [Fig. 4.6 C, E-H]. We next tested the food intake response to an exogenous ghrelin
(0.5mg/kg body mass) or overnight fasting challenge, and found that, like chow-fed mice, HFDfed AGKO and f/f control mice had comparable food intake following both ghrelin and fasting
[Fig. 4.6 I-J]. In addition, AGKO and f/f mice have comparable 24 h food intake suggesting
sensory neuron GHSR knockout does not affect food intake on HFD [Fig. 4.6 K]. As obese can
lead to Type 2 Diabetes development in humans and mice, we tested the glucoregulatory ability
in HFD-fed AGKO and f/f mice. We found that sensory neuron GHSR deletion significantly
improved glucose disposal during a glucose tolerance test and decreased fasting glucose [Fig. 4.6
L-M]. In addition, AGKO mice had a trend of decreased circulating glucose 15 min. after an
insulin challenge [Fig. 4.6 N] and decreased ad lib fed plasma insulin concentrations [Fig. 4.6
O] suggesting these mice are more insulin sensitive compared with f/f controls.

4.4.6 HFD-fed AGKO mice have increased energy expenditure and thermogenic gene
expression
We hypothesized that the DIO resistance in AGKO mice was due to increased energy
expenditure as we found chow-fed mice had increased energy expenditure and thermogenic
capacity [Fig. 4.4 and Fig. 4.5]. Indeed, HFD-fed AKO mice had significantly increased energy
expenditure during both daytime and nighttime compared with f/f control mice [Fig. 4.7 A-B].
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In addition, AGKO mice had significantly decreased respiratory quotient during nighttime hours
indicating a preferential utilization of fatty acids as fuel [Fig. 4.7 C-D]. In contrast, there was no
difference in the activity levels between fl/fl and AGKO mice (data not shown). We next
examined adipose tissue gene expression with a focus on thermogenic genes as these were
upregulated in chow-fed animals. We found a significant increase in numerous thermogenic and
browning genes in iBAT [Fig. 4.7 E], eWAT [Fig. 4.7 F], and iWAT [Fig. 4.7 G] when
compared with f/f control mice suggesting the increased energy expenditure is due to
upregulated thermogenic pathways in adipose tissue. Moreover, we found significantly higher
UCP1, TH, and a trend of increased pHSL protein content in AGKO iBAT compared with f/f
animals [Fig. 4.7 H]. We observed a trend of increased TH protein in AGKO eWAT and
significantly higher pHSL protein in AGKO iWAT compared with f/f control mice [Fig. 4.7 I-J].

We next performed H&E staining and UCP-1 IHC in fat tissues to confirm our gene and
protein expression data.

We found that f/f mice had significantly larger adipocyte cell size in

iBAT compared with AGKO mice [Fig. 4.8 A, B], and significantly less iBAT UCP-1 staining
when compared with AGKO mice [Fig. 4.8 C, D]. Moreover, compared with f/f mice, we found
a marked reduction in adipocyte size in AGKO eWAT [Fig. 4.8 E, F], iWAT [Fig. 4.8 I, J], and
significantly decreased liver lipid deposits [Fig. 4.8 G, H].

4.4.7 AGKO mice are markedly more cold tolerant
The marked increase in adipose tissue thermogenic genes would suggest AGKO mice
have a greater capacity to maintain body temperature during a cold challenge. Hence, we next
tested the thermoregulatory ability in AGKO and f/f mice during an acute (1 day) 4°C or chronic
(10 day) 10°C cold challenge. We found that AGKO mice had significantly increased baseline
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body temperature and were able to more rapidly normalize their temperature compared with f/f
control mice in response to an acute 4°C cold challenge [Fig. 4.9 A]. In addition, AGKO mice
had significantly increased core body temperature at several time points during a 7 day 10°C
challenge and as measured by area under the curve [Fig. 4.9 B-C]. We next examined adipose
thermogenic gene expression in these mice and found that a 1 day 4°C cold challenged AGKO
mice had significantly increased thermogenesis and browning genes in iBAT, eWAT, and iWAT
[Fig. 4.9 D-F]. Similarly, we found a 7 day 10°C challenged AGKO mice had significantly
upregulated thermogenic genes in iBAT, eWAT, and iWAT [Fig. 4.9 G-I].

We further examined adipose depots from 1 day and 7 day cold exposed animals using
H&E and UCP-1 IHC analysis. H&E staining was comparable for 1 day cold exposed f/f and
AGKO iBAT and eWAT [Fig. 4.10 A, B and E, F], although AGKO mice had significantly
increased UCP-1 IHC staining in iBAT [Fig. 4.10 C, D] and eWAT [Fig. 4.10 G, H]. H&E
stained iWAT in AGKO mice had a more BAT-like morphology compared with f/f mice [Fig.
4.10 I, J], and iWAT UCP-1 IHC revealed markedly more staining for AGKO mice compared
with f/f mice [Fig. 4.10 K, L]. Our analysis of adipose tissues from 7 day cold exposed animals
complemented 1 day tissue analysis. Compared with f/f mice, 7 day cold exposed AGKO mice
had significantly darker H&E stained iBAT [Fig. 4.10 M, N], eWAT [Fig. 4.10 Q, R], and
iWAT [Fig. 4.10 U, V]. Moreover, we found a marked increase in UCP-1 IHC staining in
AGKO iBAT [Fig. 4.10 O, P], eWAT [Fig. 4.10 S, T], and iWAT [Fig. 4.10 W, X] as compared
with f/f mice.

We next sought to further study whether increased BAT thermogenesis and WAT beiging
in AGKO mice during cold exposure was due to increased sympathetic activity by measuring TH
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protein levels using Western Blot analysis. We found 1 day cold exposure significantly
increased AGKO TH protein in iBAT [Fig. 4.11 A] and iWAT [Fig. 4.11 C], but not in eWAT
[Fig. 4.11 B]. In addition, 7 day cold exposed AGKO mice also had a trend of increased TH
protein in iBAT [Fig. 4.11 D], eWAT [Fig. 4.11 E], and iWAT [Fig. 4.11 F]. Interestingly, we
also found a significant increase in iWAT pHSL in 7 day cold exposed AGKO mice [Fig. 4.11
F].
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Fig. 4.1 GHSR-positive neurons emanate from DRGs.
Average number of stomach, small intestine, or large intestine injected Fast Blue positive
neurons in the vagus and L5/6-C1 DRG levels (A) (n=8). Average number of GFP-positive
neurons in the vagus and T12-T5 DRG levels (B) (n=8). Representative fluorescent image of
T10 level DRG stained for GFP (C) and Fast Blue (D), and superimposed images showing
colocalization of staining (E). Average number of GFP-positive neurons labeled with Fast Blue
and number of Fast Blue-positive neurons expressing GFP that project to the stomach (F) or
small intestine (G) (n=4-6 per group). Representative electrophysiology recording from GFPpositive DRG neurons given 100 nmol ghrelin (H). Representative patch clamp recording from
GFP-positive DRG neuron given either vehicle (green trace) or 100 nmol ghrelin (blue trace) (I).
Quantification from all GFP-positive DRG patch clamp experiments (J) (n=6 neurons). Average
intracellular calcium change for GFP-positive and GFP-negative DRG neurons given either 100
nmol ghrelin (Ghrl.) or vehicle (Veh.) (K), and the maximum change in fluorescence (L) (n=5-12
neurons per group). White arrows in C-E denote GFP and Fast Blue double labeled neurons.
Data reported as mean ± S.E.M. *P<0.5 vs. baseline.
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Fig. 4.2 GHSR-positive sensory neurons are activated by energetic challenges.
Relative GHSR expression in the arcuate nucleus, lumbar DRGs, Thoracic DRGs, or Cervical
DRGs following 12h food deprivation (A) or 24h cold exposure challenge (E) (n=4 per group).
Average number of GHSR-positive neurons in the vagus and T12-T5 DRG levels following 12h
food deprivation (B) or 24h cold exposure challenge (F) (n=4-6 per group). Number of triple
labeled (GFP, cFos, and Fast Blue) neurons projecting to the stomach (C) or small intestine (D)
following a 12h food deprivation challenge (n=4-5 per group). Number of triple labeled (GFP,
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cFos, and Fast Blue) neurons projecting to the stomach (G) or small intestine (H) following a
24h cold exposure challenge (n=4-5 per group). Representative T7 DRG level fluorescent
immunostaining for GFP (I), cFOS (J), Fast Blue (K), and superimposed labeling showing
colocalization (L). White arrows in I-L denote GFP, cFos, and Fast Blue triple labeled neurons.
Data reported as mean ± S.E.M. *P<0.5 vs. ad libitum fed or room temperature control animals.
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118
A

B
3.2e+5

f/f
AGKO

* *

*

4000

*

**

*
*

f/f
AGKO

2.8e+5

AUC

VO2 (ml/h/kg)

5000

*

2.4e+5

3000

2.0e+5
2000
07:21 13:12 19:03 01:21 07:12 13:03 18:54 00:45 07:03 12:54 18:45 00:36 06:54

1.6e+5

Day

Night

Time

C

0.9

75

* **

f/f
AGKO

70

**

AUC

RER

D

f/f
AGKO

1.0

0.8

65
60

0.7

55

0.6

50

07:21 13:12 19:03 01:21 07:12 13:03 18:54 00:45 07:03 12:54 18:45 00:36 06:54

Day

Night

*

f/f
AGKO

Time

1
pUc

ea
id

b
t1
Cp

3
pUc

4

0
AR
B3

H

P<0.1

2
1
pUc

o2
Di

3
pUc

B

*

*

0.8
0.0

UCP-1

TH

pHSL

f/f
AGKO

P<0.1

2.0
1.5
1.0
0.5

0.0

UCP-1

UCP-1

TH

TH

pHSL
Tubulin

UCP-1

TH

pHSL

AGKO

P<0.1

1

AR
B3

3.0

f/f
AGKO

2.0

*
*

1.0
0.0

UCP-1

TH

pHSL

UCP-1
TH
pHSL

pHSL

f/f

P<0.1

J
2.5

Relative Expre s sion

Relative Expression

1.6

f/f
AGKO

*

0
R
3A

I
2.4

2

dm
16

0.0

*

Pr

0.5

3
Relative Expression

1.0

f/f
AGKO

cp
-1
D
io
2
Ci
de
a
U
cp
-3

P<0.1

*

Relative Expression

1.5

G

45
30
15
6

U

*

P<0.1

2.0

C

Relative Expression

F

f/f
AGKO

2.5

Relative Expression

E

Tubulin

Tubulin

f/f
f/f

AGKO

AGKO

Fig. 4.4 Chow-fed AGKO mice have upregulated thermogenic genes and proteins.
Average daily energy expenditure for AGKO and WT mice (A) and day/night area under the
curve values (B) (n=7 per group). Average daily respiratory quotient for AGKO and WT mice
(C) and day/night area under the curve values (D) (n=7 per group). Relative expression of
thermogenic genes in iBAT (E), eWAT (F), and iWAT (G) for AGKO and WT mice (n=8 per
group). Relative thermogenic protein content in iBAT (H), eWAT (I), and iWAT (J) for AGKO
and WT mice (n=4 per group). Data reported as mean ± S.E.M. *P<0.5 vs. WT control animals.

119
A

B

C

D

E

F

G

H

I

J

K

L

Fig. 4.5. 12 wk. chow-fed H&E and UCP-1 IHC adipose tissue histology.
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Fig. 4.7 Sensory neuron GHSR knockout mice have increased energy expenditure and
thermogenic capacity on high-fat-diet.
Average daily energy expenditure for high-fat-diet fed AGKO and WT mice (A) and day/night
area under the curve values (B) (n=7 per group). Average daily respiratory quotient for high-fatdiet fed AGKO and WT mice (C) and day/night area under the curve values (D) (n=7 per group).
Relative expression of thermogenic genes in iBAT (E), eWAT (F), and iWAT (G) for high-fat-
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diet fed AGKO and WT mice (n=8 per group). Relative thermogenic protein content in iBAT
(H), eWAT (I), and iWAT (J) for AGKO and WT mice (n=4 per group). Data reported as mean
± S.E.M. *P<0.5 vs. WT control animals.
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Fig. 4.8. 12 wk. HFD-fed H&E and UCP-1 IHC histological analysis.
Representative images of H&E stained iBAT from f/f (A) and AGKO mice (B), and
representative UCP-1 IHC iBAT images from f/f (C) and AGKO mice (D). Representative
images of H&E stained eWAT from f/f (E) and AGKO mice (F), and H&E stained liver from f/f
(G) and AGKO mice (H). H&E stained iWAT from f/f (I) and AGKO mice (J).

123

P<0.1

b

5

f/f
AGKO

*

4

P<0.1

3

*

2

P<0.1

P<0.1

1
16

R

0

0
R

0.5

A
Pr R
dm
16

b3

ar
-g

Pp

1

Ci
de
a
Co
x1
Uc
p3
b3
AR

C

b

b3
A

1
pt

-a
Pp
ar

Uc
p

-1

0.0

1.0

I

P<0.1

P<0.1

Pr
dm

0.5

P<0.1

2

P<0.1

1.5

0.0

16

*

3

P<0.1

b3
A

1.0

P

m
rd

f/f
AGKO

2.0

-3

P<0.1

3
a
3 b
de vl t1 pCi Elo Cp Uc

f/f
AGKO

-a

1.5

H 4

-1

Pp
ar

*

p
Uc

F

AGKO

cp

f/f
AGKO

0.0

-1

*

2.0

16

P<0.1

0.5

Uc
p

G 2.5

Pr

dm

P<0.1

1.0

1b

a 3 1 1 b 3
de vl ox ox t1 pCi Elo Ac C Cp Uc

AR

-1

Pp
ar
-g

p
Uc

* *
P<0.1

1.5

c-

*

1
0

Relative Expression

*

Pg

* * * *

Relative Expression

* *

2

*

2.0

Relative Expression

6
3

b3

Relative Expression

f/f
AGKO

*

f/f
AGKO

2.5

g
El
ov
l3

E
9

f/f

cp
-1

D
12

1740

Time (h)

b3

13 25 55 77 99 121 143 153

t1

6

Cp

0

U

5

U

4

Pp
ar
-

2
3
Time (h)

1760

1b

Baseline 1

33

1780

Pg
c-

26

34

1800

Co
x1

28

35

1820

a

30

*

*

1840

ar
-

32

*

*

*

36

1860

Pp

* *

37

AUC (Arbitrary Units)

34

f/f
AGKO

Relative Expression

p<0.1
p<0.1

C

38

Relative Expression

*

36

B

f/f
AGKO

AR

38

Temperature (oC)

Body Temperature (C)

A

Fig. 4.9 Sensory neuron GHSR knockout mice have increased cold tolerance.
Body temperature measurements in AGKO and WT mice following an acute 4°C cold challenge
(A) (n=5-7 per group). Body temperature measurements in AGKO and WT mice following a 7
day 10°C cold challenge (B) and area under the curve values (C) (n=10 per group). Relative
expression of thermogenic genes in iBAT (D), eWAT (E), and iWAT (F) for acute 4°C cold
challenged AGKO and WT mice (n=5-7 per group). Relative expression of thermogenic genes in
iBAT (G), eWAT (H), and iWAT (I) for 7 day 10°C cold challenged AGKO and WT mice (n=10
per group). Data reported as mean ± S.E.M. *P<0.5 vs. WT littermate control animals.

124
A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Fig. 4.10. 1 day and 7 day cold exposure H&E and UCP-1 IHC adipose tissue histology.
Representative images of 1 day cold exposed H&E stained iBAT from f/f (A) and AGKO mice
(B), and representative UCP-1 IHC iBAT images from 1 day cold exposed f/f (C) and AGKO
mice (D). Representative images of H&E stained eWAT from 1 day cold exposed f/f (E) and
AGKO mice (F), and representative UCP-1 IHC eWAT images from 1 day cold exposed f/f (G)
and AGKO mice (H). Representative images of H&E stained iWAT from 1 day cold exposed
f/f (I) and AGKO mice (J), and representative UCP-1 IHC iWAT images from 1 day cold

125

exposed f/f (K) and AGKO mice (L). Representative images of 7 day cold exposed H&E stained
iBAT from f/f (A) and AGKO mice (B), and representative UCP-1 IHC iBAT images from 7 day
cold exposed f/f (C) and AGKO mice (D). Representative images of H&E stained eWAT from 7
day cold exposed f/f (E) and AGKO mice (F), and representative UCP-1 IHC eWAT images
from 7 day cold exposed f/f (G) and AGKO mice (H). Representative images of H&E stained
iWAT from 7 day cold exposed f/f (I) and AGKO mice (J), and representative UCP-1 IHC
iWAT images from 7 day cold exposed f/f (K) and AGKO mice (L).
B

1.2
0.8

0.4
0.0

TH

C
2.5
2.0
1.5
1.0

0.5
0.0

pHSL

pHSL

pHSL

Tubulin

Tubulin

1.6

1.2

AGKO
f/f
AGKO

p<0.1

0.8
0.4
0.0

TH

pHSL

AGKO

5
4

p=0.06

f/f
AGKO

3

2
1

0

1.0
0.5
0.0

pHSL

TH

pHSL

F

3.0

pHSL

f/f

AGKO

0.0

TH

TH
pHSL
Tubulin

f/f

AGKO

*

1.0

pHSL
Tubulin

f/f
AGKO
p<0.1

TH

AGKO

TH

2.0

pHSL
Tubulin

f/f

*

1.5

f/f
AGKO

TH
pHSL
Tubulin

f/f

E
Relative Expression

f/f

Relative Expression

TH

TH

TH

D

2.0

f/f
AGKO

Relative Expression

*

f/f
AGKO

Relative Expression

Relative Expression

1.6

Relative Expression

A

TH

pHSL

f/f

AGKO

Fig. 4.11 1 day and 7 day adipose tissue western blot analysis.
Relative thermogenic protein content in iBAT (A), eWAT (B), and iWAT (C) for acute 4°C cold
challenged AGKO and WT mice (n=5-7 per group). Relative thermogenic protein content in
iBAT (D), eWAT (E), and iWAT (F) for 7 day 10°C cold challenged AGKO and WT mice (n=4
per group).

4.5

Discussion
In the current study, we have identified a novel ghrelin signaling mechanism through

which peripheral sensory neurons mediate energy expenditure and adipose tissue metabolism
independent of central GHSRs. While central GHSR signaling has been extensively studied, the
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mechanisms through which ghrelin activates peripheral sensory neurons has received
considerably less attention. We have identified here broad GHSR expression on DRGs that
respond to ghrelin both in vitro and in vivo, and confirm previous reports demonstrating the
presence of ghrelin responsive sensory neurons in the nodose ganglia. Many of these GHSR
expressing DRG neurons project to the stomach and are activated by both food deprivation and
cold exposure. Interrogating the physiological role of these neurons in the context of metabolic
homeostasis necessitated the generation of a novel, sensory neuron specific GHSR knockout
mouse. We crossed our sensory neuron specific advillin-cre mouse driver line with the newly
developed ghsrf/f mouse to generate AGKO mice. These mice have increased energy
expenditure, thermogenic capacity, and attenuated HFD-induced obesity. Collectively, our
results demonstrate a novel mechanism through which ghrelin regulates whole body energy
homeostasis.
Given the multitude of studies demonstrating ghrelin’s role in obesity development and
pathological conditions such as Prader-Willi Syndrome [25, 59-61], it is unsurprising ghrelin has
emerged as an important regulator of metabolic homeostasis. Within the brain, GHSRs are
expressed across the neuroaxis including on agouti-related protein/neuropeptide Y expressing
neurons (AgRP neurons) in the hypothalamic arcuate nucleus (Arc) [16, 23]. Discrete AgRP
neuron activation is sufficient to rapidly drive food intake [62], and ablation of these neurons in
adults results in profound hypophagia [63, 64]. AgRP neurons can mediate ghrelin’s orexigenic
effects independent of other central nuclei or peripheral GHSR activation [65], and these neurons
have been extensively studied in the context of ghrelin signaling and obesity development.
However, GHSRs are also expressed on the vagus nerve and in numerous hindbrain nuclei
involved in metabolic control including the dorsal motor vagus (DMV) and nucleus tractus

127

solitarius (NTS), and fourth ventricular ghrelin infusion is sufficient to drive food intake
independent of forebrain nuclei [66-68]. The DMV and NTS receive significant peripheral
sensory information from the vagus nerve and DRGs, and these nuclei are critical for modulating
sympathetic outflow [69-72]. Vagal GHSRs were initially hypothesized to be necessary and
sufficient to ghrelin signaling [41], yet subsequent studies in vagotomized animals found no
change in, at the very least, ghrelin-induced food intake [73]. Our finding here that GHSRs are
also expressed in DRGs, and that total sensory neuron GHSR deletion (i.e. on both vagal and
DRGs) imparts a beneficial metabolic phenotype, suggests a possible DRG-involved
compensatory mechanism that is sufficient to mediate ghrelin’s peripheral effects independent of
the vagus. Indeed, Dass et al. found that exogenous ghrelin elicits prokinetic activity in rat and
human gastric preparations and hypothesized these effects are mediated by both vagal and
enteric innervation [46].
The broad GHSR distribution on both vagal and DRG neurons strongly suggests the
presence of parallel central and peripheral mechanisms regulating ghrelin’s downstream effects
on energy expenditure. Our finding that sensory neuron specific GHSR knockout attenuates DIO
development furthers our understanding of ghrelin’s role in obesity development, and
complements previous studies showing global GHSR ablation affords similar obesity resistance
and improved glycemic regulation. This improved insulin sensitivity and glucose disposal
manifests as diabetes resistance in HFD-fed animals, yet the absence of ghrelin signaling in
whole body GHSR knockout mice results in hypoglycemia during fasting [25, 74]. Selective
GHSR restoration in AgRP neurons or hindbrain Phox2b expressing neurons restores fasting
glucose levels suggesting these neurons are sufficient to mediate ghrelin’s glucoregulatory
effects [29, 75]. However, Phox2b is expressed in both hindbrain and peripheral sensory
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neurons [76, 77], and it is therefore impossible to delineate the central or peripheral mechanism
mediating this effect. Our results demonstrating that peripheral, sensory neuron specific GHSR
knockout has no effect on fasting glucose levels in chow-fed animals would suggest the
improved glucoregulation in Phox2b GHSR-restored mice involves a central mechanism.
Because GHSRs are ablated in both DRG and vagal neurons, we hypothesize that neurons
downstream of the DMV and NTS, including Arc AgRP neurons [10, 11, 78], regulate glucose
metabolism. On the other hand, the mild improvement of insulin sensitivity in HFD-fed AGKO
mice may be secondary to their protection from diet-induced obesity.
Previous GHSR knockout studies have shown that, despite comparable food intake to
WT mice, obesity resistance is due to a marked upregulation in energy expenditure mediated by
increased sympathetic outflow to adipose tissue [25, 27, 61]. The dissociation between ghrelininduced food intake and augmented energy expenditure suggests discrete nuclei regulate these
effects. To this end, adipose tissue sympathetic outflow neurons are found in numerous
hindbrain and forebrain nuclei [11, 79], and many of these nuclei concurrently integrate
peripheral sensory neuron information to regulate energy expenditure [10, 80]. We have
identified here a novel peripheral GHSR signaling mechanism that functions to decrease energy
expenditure, and we hypothesize this circuit elicits its effects through two possible mechanisms.
First, ghrelin signaling on sensory neurons may decrease energy expenditure through short
feedback loops at the level of the spinal column. In support of this, sensory-sympathetic cross
talk at the level of the spinal cord exists in gastrointestinal system [81], and spinal column
damage impairs normal gastric function despite intact vagal signaling [82]. Second, and more
plausibly, ghrelin-mediated energy expenditure may be mediated through sensory integration in
hindbrain nuclei. Previous work has demonstrated fourth ventricular ghrelin injections is
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sufficient to decrease energy expenditure and elicit neuronal activity in several hindbrain nuclei
that receive sensory neuron input including the DMV and NTS [66, 67]. As these neurons also
send sympathetic projections to adipose tissue, it is likely that peripheral ghrelin signaling
inhibits these neurons in WT animals. Hence, we find increased thermogenic gene expression in
iBAT, eWAT, and iWAT pads in our AGKO knockout mice, possibly due to an upregulated
sympathetic response, as shown by increased β3AR mRNA and TH protein levels. This
upregulated energy expenditure paradigm following peripheral GHSR ablation is an important
finding in the context of clinical approaches to combat obesity. Because our animals have
normal glucose regulation and food intake while simultaneously resisting obesity, a treatment
regimen targeting peripheral ghrelin signaling would prove beneficial as it has fewer side effects
compared with non-specific GHSR antagonism and would circumvent the need to bypass the
blood brain barrier. In turn, our results may provide a novel approach for obesity treatment.
The marked upregulation of thermogenic genes across iBAT, eWAT, and iWAT
engender improved thermoregulation during an acute or chronic cold challenge and provides a
mechanism for the elevated energy expenditure that attenuates obesity development. Although
global and neuronal GHSR knockout mice have upregulated thermogenic genes in adipose
tissues [25, 27, 74], to our knowledge this is the first demonstration that sensory neuron GHSR
signaling functions to decrease expression of these genes. While the exact mechanism through
which the absence of GHSR signaling increases adipose thermogenic gene expression
necessitates further study, we propose a mechanism involving gut-brain crosstalk. We have
shown here both vagal and DRG GHSR-positive neurons innervate the stomach and small
intestine [Fig. 1], and nutrient activation of gut afferents is sufficient to increase iBAT
temperature [9]. Because endogenous ghrelin signaling inhibits these enteric sensory neurons
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[41, 83], it is likely that the absence of GHSRs results in a chronic, uninhibited afferent activity
that drives adipose thermogenic gene expression. In addition, the same study found that NTS
NMDA blockade inhibited this nutrient-induced increase in iBAT activity [9], and, given the
colocalization of gastric afferents in the NTS, it is likely that GHSR activation of these neurons
would similarly decrease glutamatergic NTS neuron activity.
In sum, our results demonstrate a novel peripheral ghrelin signaling pathway that
responds to energetic challenges and regulates metabolic homeostasis. As this pathway is
independent of central ghrelin signaling, it strongly suggests the presence of multiple ghrelininvolved mechanisms that regulate whole body energy homeostasis. Hence, peripheral ghrelin
signal intervention may provide novel therapeutic approaches that increase basal energy
expenditure and prevent or reverse obesity.
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5

CONCLUDING REMARKS
This dissertation serves as an important step forward in our understanding of how the

orexigenic hormone ghrelin regulates whole body energy homeostasis. We approached these
studies with a complementary focus on interrogating the behavioral and physiological
mechanisms through which ghrelin mediates metabolism. We have expanded the known role of
ghrelin in driving ingestive behaviors by demonstrating 1) central ghrelin signaling is necessary
and sufficient to drive appetitive and consummatory behaviors, 2) central ghrelin acts through
AgRP neurons to drive these behaviors, and 3) AgRP signaling is necessary for the long-term
increases in food hoarding following an exogenous ghrelin challenge or fasting. Moreover, we
have identified a novel peripheral sensory neuron ghrelin signaling pathway that is critical for
metabolic regulation. The novelty of this work lies in the multifaceted behavior and physiology
experimental paradigms that contrast with approaches aimed at a single outcome (e.g. food
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intake). Hence, we have elucidated ghrelin’s role in two discrete mechanisms that drive
excessive weight gain.
Our finding that central GHSR activation is necessary and sufficient to drive ingestive
behaviors and the chronic increases in food hoarding is regulated by AgRP peptide signaling
complements previous studies in other laboratory rodent species [134, 180, 181]. The long-term
behavioral adaptation in which animals, including humans, hoard food to prevent future caloric
deficiencies is a major contributor to weight regain following dieting. Our results here serve as a
critical step toward understanding the mechanism through which this is mediated. However, the
downstream nuclei that regulate long-term food hoarding remain to be identified. AgRP neurons
project to numerous nuclei involved in food intake and/or energy expenditure control [95], and
advances in neuron specific circuit mapping is an attractive approach to interrogate the role of
these projections in the context of appetitive behaviors. Discrete Arc→PVH projections are
likely critical for driving food intake, and several studies have demonstrated selective activation
of these projections drives food intake comparable to total AgRP neuronal activation [95]. We
show here that central GHSR antagonism blocks appetitive and consummatory ingestive
behaviors and PVH neuronal activity while leaving the Arc relatively unaffected [28]. Because
redundant AgRP projections to downstream nuclei sufficient to drive food intake exist, it may be
possible that non-PVH nuclei receiving AgRP neuron input are also sufficient to mediate other
ingestive behaviors. Unfortunately, the genetic models required for neuron-specific mapping are
available only in mice and, to a lesser extent, rats. It is therefore impossible to employ the
spatial and temporal experimental resolution necessary to directly test this in Siberian hamsters.
In an evolutionary context, a dual physiological approach that simultaneously drives
energy consumption and energy conservation would markedly increase an animal’s survival
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probability. However, these adaptive responses must be balanced as food foraging inherently
requires energy expenditure. The mechanisms through which this balance is maintained and at
what point animals stop appetitive behaviors in favor of conserving energy remains unclear, yet
converging experimental and anecdotal evidence suggests unconstrained, elevated circulating
ghrelin concentrations causes this switch. Central GHSR responsive neurons (i.e. within the
Arc) may be more sensitive to circulating ghrelin or require significantly fewer neurons to be
activated to elicit ingestive behaviors compared with peripheral GHSR neurons. Prolonged
caloric restriction results in unimpeded stomach ghrelin production and AgRP neuron
upregulation and may in turn reach a plateau at which point higher circulating ghrelin cannot
further drive ingestive behaviors. Because GI-derived anorectic hormones that oppose ghrelin’s
peripheral sensory neuron effects would concurrently reach nadir, elevated ghrelin
concentrations would maximally activate vagal and DRG sensory neurons causing a switch to
energy conservation rather than ingestive behaviors. In support of this hypothesis, activation of
as few as 400 AgRP neurons is sufficient to drive maximum food intake in mice [95], and we
have observed very large ghrelin doses (~1mg/kg i.p.) cause Siberian hamsters to remain in their
bottom hoarding cage rather than foraging for and gathering food for hoarding (Thomas and
Bartness unpublished observations). By contrast, physiological ghrelin doses (~30 µg/kg i.p.)
cause a robust increase in appetitive behaviors and drive long term behavioral adaptations [22,
28, 182]. Although the experimental and anecdotal evidence presented here would support this
hypothesis, future work is clearly needed to fully elucidate this mechanism.
The presence of GHSRs on DRG and vagal neurons raises several important, unanswered
questions. First, although DRG and vagal ghrelin signaling is necessary to mediate metabolic
homeostasis, it is unclear how this information is integrated centrally and where any
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hindbrain/forebrain crosstalk may or may not occur. Hindbrain nuclei including the NTS and
DMV receive broad peripheral sensory neuron information from DRG and vagal sensory
neurons, and these nuclei can elicit a metabolic response directly or relay this information to
hypothalamic and forebrain nuclei for further processing [37, 39, 183-185]. In addition, these
nuclei are integral in regulating sympathetic outflow to adipose tissues suggesting a possible
mechanism through which sensory neuron ghrelin signaling can regulate adipose metabolism
[38, 186-188]. These hindbrain nuclei may therefore serve to integrate peripheral GHSR
signaling and then relay this information to other central nuclei or mount a metabolic response
directly, and future work is needed to examine this hypothesis. Second, it is unclear if DRG and
vagal sensory neurons act as redundant peripheral ghrelin signaling pathways or if they drive
discrete metabolic effects. Previous work has demonstrated sensory neurons are critical for
maintaining energy homeostasis and that non-vagal sensory neurons are sufficient to mediate
ghrelin’s effects on gastric motility, but whether or not this seemingly redundant mechanism
exists in the NTS or DMV is unknown. Our novel AGKO mouse model is an important step
towards understanding how peripheral sensory neurons regulate metabolic homeostasis, but
because it inherently deletes GHSRs on all sensory neurons (i.e. both DRG and vagal) it is
unable to differentiate the discrete role of these pathways. Moreover, we are presently unable to
comment on any changes in hindbrain NTS/DMV crosstalk or downstream changes that could
account for our observed phenotype.
In sum, our work presented here will serve as a foundation from which future studies can
build upon to fully elucidate ghrelin’s role in metabolic control. The diverse behavioral and
physiological effects of ghrelin make it an attractive target for obesity reversal and prevention.
By identifying the mechanism through which ghrelin drives acute and long-term changes in
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appetitive and consummatory behaviors as well as how it regulates metabolism through
peripheral signaling pathways, we have provided clinically relevant information that can be used
to progress drug or behavioral therapies.
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